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ABSTRACT
The association between squamous cervical carcinoma and sexual
intercourse has been recognised for over a century leading
investigators to postulate that the disease is caused by a sexually
transmitted agent. Many possible candidates have been considered
but since the mid 1970s interest has centred upon the human
papillomavirus (HPV). The lesions caused by papillomaviruses tend
to be persistent and are characterised by increased proliferative
activity. HPV can be identified in the majority of cases of
invasive and pre-invasive cervical cancers. These features, as well
as the results of animal studies, make the viruses attractive
candidates for playing a part in human carcinogenesis. The work
described in this thesis was designed to examine some of the local
effects of HPV infection on squamous cervical epithelium, which
might contribute to neoplastic change.
Patients with cervical HPV infection and with pre-invasive or
invasive cervical carcinoma were studied. Their reproductive,
contraceptive, sexual, smoking and cervical smear histories were
compared with those of normal controls, and colposcopically
directed cervical punch biopsies and/or brushings obtained.
Cryostat sections were cut from punch biopsies and stained
using monoclonal antibodies to Langerhans cell (LC) and T cell
markers and to major histocompatibility (MHC) class II antigens
(HLA-DP, -DQ and -DR). In HPV infected epithelium and in cervical
intraepithelial neoplasia (CIN) grades II and III LC were
significantly reduced in number and altered in morphology and
distribution. HLA-DR expression by LC was significantly increased
in HPV infection and in CIN I and II, while HLA-DQ expression was
significantly increased in CIN I-III.
Cervical biopsy and brush specimens and pelvic lymph node
biopsies from patients with pre-invasive and invasive lesions
were prepared for flow cytometry. They were assayed for DNA
content, number of dividing cells and for c-myc oncogene protein
and papillomavirus antigen expression. Samples from women with
CIN and HPV lesions contained significantly more dividing cells
than those from controls. The proportion of DNA aneuploid samples
in the HPV group did not differ significantly from the group with
CIN III. More specimens from normal cervical epithelium were c-myc
antigen positive than specimens from CIN II or III or invasive
cancer. Papillomavirus antigens were detected in pelvic lymph
nodes free from metastatic tumour.
Patients with lymphomas were compared with normal controls.
Significantly more lymphoma patients than controls had CIN II or
III, with the increase being particularly marked in patients with
Hodgkin's disease treated with chemotherapy. Only half the cases
of CIN in lymphoma patients were detected by cervical cytology.
These results show that there is a localised disturbance in
immune function in HPV infected cervical epithelium and that HPV
infection stimulates cellular proliferation and is associated with
the development of aneuploidy. The relationship of these findings
to the proposed link between HPV infection and cervical neoplasia
is discussed, and other possible contributory factors, such as
immunosuppression, smoking, oral contraceptive pill use and
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Cervical carcinoma: historical aspects
Population data on the frequency of cancer of various organs
cannot be considered reliable prior to 1950. Nevertheless, there
appears to be little doubt that carcinoma of the uterine cervix has
been one of the leading causes of cancer mortality among adult
women for many centuries (Koss, 1981). It was not until 1930 that
Robert Meyer clearly separated carcinoma of the uterine cervix from
carcinoma of the corpus. He also distinguished 'solid'
carcinomas, comprising epidermoid or squamous cancers and their
keratinising variants, from adenocarcinomas of endocervical origin,
thus formulating a classification which is still used today. This
thesis is concerned with invasive and pre-invasive squamous
carcinoma, and not with adenocarcinoma. Where the term 'cervical
carcinoma' is used below it refers to squamous and not
adenocarcinoma.
An understanding of the sequence of morphological events in
the genesis of epidermoid carcinoma was greatly enhanced by
Schauenstein who, in 1908, published a paper on atypical surface
epithelium of the cervix. He clearly identified the surface
changes as histologically identical to those observed in invasive
cervical cancer and suggested that the abnormal surface epithelium
was the source of invasive cancer. The term 'carcinoma in situ'
(CIS) with reference to surface changes was introduced by
Schottlaender and Kermauner in 1912 and was subsequently
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popularised by Broders in 1932.
Rubin (1910) and Schiller (1927, 1928) confirmed
Schauenstein's observations and, like him, considered the surface
abnormalities to be manifestations of cervical cancer. This
belief was shaken by a study of 18 patients with cervical CIS by
Scipiades and Stevens (1938). Three of these patients received no
treatment and although two of them developed invasive cancer, one
remained free of disease. This led the great cancer pathologist,
James Ewing (1940) to the conclusion: "It thus appears that while
some of the lesions must progress and become true cancer, others
may be reversible and undergo spontaneous regression, so that a
positive diagnosis of cancer may not be given".
Ewing's statement opened the door to a controversy which has
still not been resolved. The problem became more acute with the
introduction of cytological mass screening (Papanicolaou and
Marchetti, 1943) which brought to light an unexpectedly large
number of intraepithelial abnormalities of uncertain prognosis in
asymptomatic healthy women.
It is generally accepted that invasive cervical carcinoma
develops from a pre-invasive state in which the malignant cells are
confined to the epithelium. Epidemiological studies (discussed
below) have shown that the risk factors for the invasive and the
pre-invasive conditions are identical and prevalence studies have
shown that the age distribution of the two lesions is consistent
with the progression of pre-invasion to invasion (Coleman et al.,
1986). The strongest evidence to link the pre-invasive and
invasive forms of the disease is derived from studies similar to
that of Scipiades and Stevenson (1938) in which patients with
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intraepithelial lesions are left untreated. There are many studies
purporting to show the frequency with which lesions (dysplasia,
cervical intraepithelial neoplasia or CIS) regress or progress, some
of which are listed by Patten (1978). A detailed analysis isnot
particularly revealing because of wide variations in the use of the
terms "dysplasia" and "carcinoma in-situ" and the fact that most
observations have been of lesions followed by punch biopsy, which
certainly interferes with the course of the disease (Richart, 1966).
Several studies have been published (Peterson, 1956; Kinlen
and Spriggs, 1978; Mclndoe et al, 1984) reporting progression
rates (from CIS to invasion) of 19-30%. There are difficulties in
interpreting this data. In some patients (Kinlen and Spriggs,
1978) the diagnosis of pre-invasive disease was made by cytology
without biopsy. It is well recognised that cytology is an
inaccurate method of distinguishing CIS from microinvasion (Hoffken
and Soost, 1981) so that some of the so called "progressors" may
well have had undiagnosed invasive disease initially. On the other
hand, biopsy or the subsequent healing process may reduce the
progression rate by entirely removing small lesions.
Almost the only studies in which biopsy was avoided are those
confined to "dysplasia" which was not deliberately allowed to
progress beyond the stage of CIS. These studies show that a
significant proportion of lesions classified cytologically as
"dysplasia" are capable of spontaneous regression. Estimates of
this occurrence vary widely; Stern and Neely (1964) estimated that
dysplasias regress at a rate of 35% per annum, while Richart and
Barron (1969) found that regression was uncommon and only occurred
in the mildest cases. Campion et al (1986) reported a regression
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rate to normal of only 7% in cervical intraepithelial neoplasia
grade I (CIN I) while 25% of cases of CIN I progressed to CIN III
within 20 months. These differences may reflect differences in
terminology. Peterson (1956) found that no prognostic guidance
could be obtained from the histological appearance of lesions.
More recently Spriggs and Boddington (1980) have suggested that it
may be possible to predict invasion on the basis of the presence of
parabasal dyskaryosis with poor differentiation in cytological
specimens but this view is not generally accepted.
The cervical transformation zone
It is known that in at least 90% of patients the initial
events in the development of cervical carcinoma take place within
the cervical transformation zone (TZ) (Kolstad and Stafl, 1982).
The TZ owes its existence to the increase in cervical bulk which
occurs during puberty and more markedly during pregnancy, due to
the influence of endogenous oestrogens. This increase in bulk
leads to an "unfolding" of the cervix with passive eversion of the
distal endocervical columnar epithelium on to what is anatomically
the ectocervix [see figures 1 and 2]. The presence of columnar
epithelium on the ectocervix is known as ectopy. The pH of
vaginal secretions is lower than that of endocervical mucus and, in
response to this, columnar epithelium is replaced by stratified
squamous epithelium by a process known as squamous metaplasia.
Some degree of squamous metaplasia is virtually universal during
the reproductive years. The TZ is the area between the original
squamo-columnar junction, now on the ectocervix, and the new
squamo-columnar junction, somewhere in the vicinity of the external
cervical os [see figure 2].
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PREPUBERTAL CERVIX
Figure 1 SCJ = squamocolumnar junction
SCJ SCJ
POST - ADOLESCENT CERVIX
Figure 2 SCJ = squamocolumnar junction
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In the early stages of the metaplastic process immature
squamous cells can be seen below, and pushing up, columnar cells in
a process known as reserve cell hyperplasia. These squamous cells
are believed to arise from undifferentiated "reserve cells" between
the columnar epithelium and the basement membrane (Christopherson
et al, 1979) or may possibly be derived from underlying stromal
cells (Fox and Buckley, 1982). The overlying columnar cells then
degenerate and reserve cells differentiate into immature and then
mature squamous epithelium. Mature squamous epithelium can be
distinguished from immature by the presence of surface
differentiation.
It is thought that the process of squamous metaplasia takes
approximately two to three weeks to be completed, and that during
this time the changing epithelium is especially vulnerable to
oncogenic agents (Coppleson and Reid, 1968).
The TZ is easily accessible to visual inspection. In the
1940s it was discovered that preclinical lesions could be detected
by taking a smear or scrape from the cervical TZ (Papanicolau and
Marchetti, 1943; Ayre, 1947) and examining the exfoliated cells
obtained under a microscope. Cervical cytology is still employed
as a screening technique, generally using an adapted form of the
spatula designed by Ayre (1947) [Figure 3].
Hinselmann (1933) is credited with the discovery that
preclinical lesions could also be visualised by the use of a
colposcope which provides a magnified view of the cervix and lower
genital tract. Abnormal vasculature may be identified and areas
of intraepithelial neoplasia delineated with the aid of solutions
such as acetic acid and Lugol's iodine.
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Pis. 2.—Technique for nuUiparone cervix. (1) Squamocolumnar Junction; (2) glandular
epithelium. Method of taking selective cytology teat In nulllparous cervix. Hook end (a) of
spatula fits Into cervix permitting gentle contact with equamocolumnar Junction. By rotating
spatula the entire circumference of this cancer xone may be "surface biopsied." The cells shed
from this key point show the earliest Indication of Incipient carcinoma before any lesion may
be recognisable to the naked eye.
Figure 3. The. Ayre's spatula
(from Ayre, 1947)
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Nomenclature of precancerous cervical lesions
It is clear from the studies cited above that reliable
prognostication of intraepithelial lesions is not possible. In
the 1950s, however, an attempt was made to reconcile the behaviour
of these lesions with the cytological and histological patterns of
the disease, leading Reagan et al (1953) to propose the separation
of intraepithelial lesions into two groups: CIS and atypical
hyperplasia or dysplasia. The differences were based on the
cellular makeup of the epithelium: lesions composed of small,
poorly differentiated cells were classed as CIS, while lesions made
up of better differentiated cells, especially those with a tendency
to form keratin, were classed as dysplasia. It was advocated that
the two groups of lesions have a different prognosis: CIS is the
malignant precursor of invasive cancer, whereas dysplasia is a
benign lesion of uncertain prognosis, more likely to disappear than
to progress (Christopherson, 1969).
This concept was soon found to be deficient. It was clearly
shown that invasive carcinoma may originate from well-
differentiated variants of epithelial abnormalities, including
those with keratinised surfaces (Bangle et al, 1963). The
follow-up studies, some of which are cited above, have shown that
the histological patterns of precancerous abnormalities are of no
prognostic significance. Studies of DNA content (Wilbanks et al,
1967), chromosomal abnormalities (Granberg, 1971) and behaviour in
tissue culture (Richart et al, 1967) failed to disclose any basic
differences that could be related to tissue pattern or prognosis of
these lesions. For these reasons, Richart (1967) suggested that
the term cervical intraepithelial neoplasia (CIN) be used for the
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entire morphological spectrum of squamous precancerous lesions of
the uterine cervix. CIN is divided into three grades - CIN I
corresponding to mild dysplasia, CIN II to moderate dysplasia and
CIN III encompassing severe dysplasia and carcinoma in situ
(Buckley et al, 1982). In all cases of CIN the full thickness of
the epithelium is occupied by neoplastic cells with nuclear
abnormalities, but in CIN I and II there is cytoplasmic
differentiation in the upper two thirds and one-third of the
epithelium respectively.
The epidemiology of squamous carcinoma of the uterine cervix
The epidemiology of uterine cancer was first investigated in
1842 by Rigoni-Stern, an Italian physician at the University of
Padua. He found that uterine cancer was relatively common in
married women, unusual in unmarried women and virtually absent in
nuns. The age distribution in Rigoni-Stern's stastistics, showing
that "uterine cancer" occurred first in women between 30 and 40
years of age and that it reached a peak in women between 40 and 60
years of age, strongly suggests that he was dealing primarily with
squamous cervical carcinoma. Studies performed in Canada (Gagnon,
1950) and the USA (Towne, 1955) confirm Rigoni-Stern's findings.
Since then, failure of squamous cell carcinoma of the cervix to be
reported in confirmed virgins (with one exception reported by
Mogaji, 1973) has led to an emphasis being placed upon marriage and
sexual behaviour as factors contributing to the increased risk of
developing this disease. It has emerged from a large number of
epidemiological studies that the younger a woman is when she first
experiences sexual intercourse, and the more sexual partners she
has, the greater are her chances of developing squamous carcinoma
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of the uterine cervix (see Coppleson 1969; Rotkin 1973; Spriggs
1984 for reviews of these studies). More recent work has shown
that the same risk factors apply for the development of CIN as for
invasive carcinoma (Vessey et al, 1983; Harris et al, 1986;
Zaninetti et al, 1986; Greenberg et al, 1985; La Vecchia, 1985).
It has been suggested that age at coitarche is of crucial
importance because the adolescent cervix is particularly vulnerable
to oncogenic agents due to the metaplastic process taking place at
that time (Coppleson 1969; Sebastian and Leeb 1978). It is not,
however, necessary to implicate such a mechanism as a multistage
model of carcinogenesis predicts that the incidence of epithelial
carcinomas is a function of a power (usually ranging from 4 to 6)
of the duration of exposure (Day and Brown, 1980) so that a few
years difference in age at first exposure to an oncogenic agent can
bring about a substantial increase in risk later in life.
More recent studies (Harris et al, 1986; Hellberg et al,
1986; Zaninetti et al, 1986) have found that the number of sexual
partners is of more significance in relation to risk than age at
coitarche. The sexual history of the husbands and other consorts
of patients is also important. Pridan and Lilienfeld (1971) found
that Israeli men with multiple sexual partners conferred an
increased risk of cervical cancer upon their partners. Similarly,
a British group studied the husbands of patients with cervical
neoplasia who claimed only one partner and found that these men had
had significantly more sexual partners than the husbands of healthy
controls (Buckley et al, 1981). This finding was confirmed recently
by American workers (Zunzunegui et al, 1986). Kessler (1977)
described 29 "marital clusters" of cervical neoplasia in which two
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women married (at different times) to the same man developed the
disease. Colombia has the highest incidence of cervical carcinoma
in the world (Waterhouse et al, 1976). Surprisingly, however,
Colombian female students have fewer sexual partners (Alzate, 1978)
than their North American and European counterparts (Luckey and
Nass, 1969). Male students in Colombia, on the other hand, are
much more likely to have had sexual intercourse with a prostitute
(Alzate, 1977) than are their counterparts in North America and
Western Europe.
The above data strongly suggest that some men may act as a
"reservoir" for a carcinogenic agent. These men have been
described as "high risk males" (Singer et al, 1976).
The aetiology of squamous carcinoma of the uterine cervix
Introduction
The epidemiological evidence cited above has led workers over
the last three decades to investigate the oncogenic potential of
any agent transmitted by sexual intercourse. These investigations
are discussed below.
Futher epidemiological studies have implicated cigarette
smoking and oral contraceptive use as possible risk factors in the




Smegma was believed to be relevant because of the apparent
association between non-circumcision of the male partner and
cervical cancer. This association has now been found to be
spurious (Terris et al, 1973).
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2. Spermatozoa
It has been shown that spermatozoa may enter cells in vitro
and alter the genome and biochemical activity of cells in culture
(Bendich et al, 1976) and recent work has demonstrated that sperm
protamines may be able to transform cervical cells in culture
(French et al, 1987). It is known that the amount of protamine in
sperm varies between individual males (Reid et al, 1978) and it is
possible that men with a high sperm protamine content are the so-
called "high risk males" (Singer et al, 1976).
3. Infectious agents
a) Herpes simplex virus
Herpes simplex virus type 2 (HSV 2) came under suspicion when
cervical cytologists noticed evidence of cervical HSV infection
coexisting with dyskaryosis (the cytological equivalent of
dysplasia) more frequently than anticipated (Naib et al, 1966).
One study demonstrated a six-fold increase in atypical cervical
smears amongst patients with genital HSV infection (Nahmias et al,
1971) and it was then found that patients with cervical neoplasia
were more likely to have antibodies to HSV 2 than were age matched
controls (Rawls et al, 1973; Aurelian et al, 1973). These studies
can be criticised on a number of grounds, some of which are
discussed by Rotkin (1976). First, the sexual history of patients
and controls was not obtained. The more sexual partners a woman
has, the more likely she is to be exposed to HSV 2 infection. The
studies cited above (Rawls et al, 1973; Aurelian et al, 1973)
showed that a higher percentage of women with cervical cancer had
anti-HSV 2 antibodies than did the controls but this may simply
mean that the women with cancer had had a greater number of sexual
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partners than had the controls. It is of interest that a recent
Czechoslovakian study of over 10,000 women found no significant
difference in levels of anti HSV 2 antibodies between patients with
CIN or cervical carcinoma and healthy controls when controls and
patients were matched for age at coitarche (Vonka et al, 1984).
Secondly, there was great variability in the percentage of cervical
carcinoma patients with anti-HSV 2 antibodies, even in tests
carried out by the same researchers on patients in different
socioeconomic groups (zur Hausen 1983). Finally, the fact that
cervical cancer patients are more likely to have anti-HSV 2
antibodies than are controls means that they are more likely to
have acquired HSV 2 infection but does not mean that there is a
direct causal link between the infection and cervical cancer.
Exhaustive attempts have been made to obtain more direct proof
that HSV 2 plays a carcinogenic role but these have been largely
unsuccessful. Infectious HSV 2 has been isolated from cervical
tumour cells in vitro on only one occasion (Aurelian, 1971). In
1972 Frenkel et al reported the isolation of 3.5 copies per cell of
a fragment of HSV-2 DNA equivalent to 40% of the total viral genome
in one individual cervical carcinoma. Other workers (zur Hausen et
al, 1974; Pagano et al, 1975; Cassai et al, 1981) have been
unable to repeat this. HSV 2 RNA has occasionally been isolated
from cervical carcinomas but no particular sequence has been
isolated on a consistent basis (Maitland et al, 1981). Recent
reports of cross hybridisation between HSV DNA and human cellular
nucleic acids (Maitland et al 1981 and Peden et al 1983) make the
significance of the results reported above somewhat uncertain.
It is known that HSV is an efficient inducer of chromosomal
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aberrations, that it can cause selective gene amplification and can
transform rodent cells in culture (zur Hausen, 1983). Possibly
the virus initiates malignant change by a "hit and run" mechanism,
as proposed by Galloway and McDougall (1983). This would explain
the absence of viral DNA within malignant cells. Zur Hausen (1982)
has postulated that HSV 2 and HPV may act as co-carcinogens while
Winkelstein et al (1984) have suggested that cigarette smoking and
HSV 2 infection may be jointly responsible for inducing malignant
change, together with other possibly unknown agents,
b) The human papillomavirus (HPV)
i) General
The papillomaviruses belong to the Papovaviridae family and
contain double stranded, circularly closed DNA within an
icosahedral capsid. HPVs cause proliferative lesions of squamous
epithelium, including that of the genital tract. So far 45 HPV
types have been described, on the basis of DNA homology. Types
are considered independent if there is less than 50%
cross-hybridisation, and the types generally associated with
genital tract lesions are HPV 6,11, 16,18 and 30. The other types
listed in table 1 are involved in only a small minority of genital
lesions.
Standard virological approaches to the study of HPV have been
limited by the lack of a tissue culture system for viral
propagation in vitro. Thus, in order to obtain viral DNA for use
as a probe, DNA must be purified from biopsy material and cloning
techniques then used to allow DNA amplification in bacteria. HPV
replication is highly dependent on the differentiation of squamous
epithelial cells and the productive functions of the virus
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including DNA synthesis and the expression of late viral genes
occur only in fully differentiated squamous epithelial cells. In
skin, viral DNA synthesis has been detected by in situ
hybridisation only in the cells of the stratum spinosum and of the
granular layer of the epidermis, and not in the basal layer or in
the underlying dermal fibroblasts. Viral capsid protein production
and virus assembly occur only in the upper stratum spinosum and in
the granular layer where keratinocytes are terminally
differentiated. It is generally believed that the viral genome is
present in a small proportion of basal keratinocytes and that the
expression of specific viral genes in the basal layer and in the
deeper layers of the epidermis is responsible for the proliferation
of epithelial cells that is characteristic of a wart or a condyloma
(Howley et al, 1986). The control of papillomavirus late gene
expression, therefore, appears tightly linked to the state of
differentiation of the squamous epithelial cells. The molecular
basis for this control is not yet known. A similar pattern is
seen within genital warts with HPV capsid antigens being detected
only in the more superficial layers (Jensen et al, 1985) while
viral DNA is thought to be present throughout the entire epithelial
thickness.
ii) Benign cervical lesions
HPV induced cervical lesions may be exophytic in nature, and
similar in appearance to common skin warts, or flat, and invisible
to the naked eye (Figure 4). The exophytic lesions are known as
condylomata (from the Greek "kondulos" meaning a knuckle)
acuminatum (from the Latin "acuminare" meaning "to make pointed"
and referring to the tapering profile of the rough surface
16.
Table 1
HPV types associated with genital lesions






























(taken from De Villiers, 1987)
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Figure 4. HPV associated lesions of the uterine cervix
A. Condyloma acuminatum
B. Flat koilocytic. lesion
(reproduced with permission from an original
drawing by Dr S. Fletcher).
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processes). No agreement has been reached upon the correct
nomenclature for the flat lesion although a recent suggestion is
that it should be described as "flat koilocytosis" (Fletcher,
1983). Another form of condyloma of "endophytic nature with
pseudoinvasive aspects" has also been described (Meisels et al,
1977). It is generally accepted that this appearance is due to
koilocytic changes within a branching, epidermidised gland
(Fletcher, 1983).
Cervical HPV infection can be identified cytologically by the
presence of dyskeratotic cells, bi- or multi nucleate cells, and
koilocytes among the exfoliated cells. Koilocytes (which were
previously described as "halo" or "balloon" cells) possess a
prominent perinuclear halo which fails to stain with eosin or
periodic acid - Schiff. They were first described in vaginal
smears by Papanicolau (1933) but it was not until 1960 that they
were first firmly associated with condylomata acuminatum
(Papanicolau, 1960). About 2% of cervical smears contain
koilocytes (Meisels and Fortin, 1976). In 1968 Dunn and Ogilvie
demonstrated viral particles compatible with HPV within koilocytes
by electron microscopy, confirming the association, although some
workers still believe that the halo may be due to non-specific
cytopathic effects (Koss, 1979). Like HSV, HPV was first
suspected as a possible aetiological agent in cervical neoplasia
when cytologists noticed evidence of cervical HPV infection
coexisting with dyskaryosis more often than would be anticipated by
chance. Meisels and Fortin (1976) and Purola and Savia (1977)
noted that koilocytes were present in cervical smears taken from
women with CIN more frequently than in smears taken from women with
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normal cervices and this, together with reports that condylomata
acuminatum could undergo malignant change (Dawson et al., 1965;
Gardner and Kaufman, 1965; Kovi et al, 1974) led Meisels et al
(1977) to propose that both "flat condylomata" and condylomata
acuminatum were precursors of CIN.
iii) Genital neoplasia
In CIN HPV virions have been identified by electron microscopy
(Ferenczy et al, 1981) and viral antigens can be demonstrated
within the more superficial epithelial cells (Kurman et al., 1981).
The detection rate of viral structural antigens decreases as the
lesion becomes more severe (McCance et al, 1983; Walker et al,
1983). It is thought that this is due to a loss of
differentiation in the more severe lesions because, as discussed
above, HPV replication is hightly dependent upon the
differentiation of epithelial cells.
DNA hybridisation studies have demonstrated that HPV types 6
and 11 are most commonly seen in cervical and other genital warts
(Gissmann and zur Hausen, 1980), and are also associated with CIN,
usually of grades I and II (Gissmann et al, 1984; McCance et al,
1985a). HPV 16 and 18 are consistently associated with the
majority of invasive squamous carcinomas of the cervix with HPV 16
found in 60-90% (McCance et al, 1985a; Durst et al, 1983) and HPV
18 in 15-36% of invasive carcinomas (Boshart et al, 1984). HPV 31,
found most often in North America, is associated with approximately
20% cases of CIN but is rarely associated with invasive disease
(Lorincz et al, 1985). HPV 16 is also found in CIN and is isolated
at an increasing rate as the disease increases in severity, with
70-75% of CIN III lesions containing HPV 16 (McCance et al, 1985a).
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HPV 16 DNA has been detected in one cervical adenocarcinoma
(Smotkin et al, 1986) but it is possible that the DNA originated in
an adjacent area of CIN, as in a significant proportion of patients
cervical adenocarcinoma is reported to coexist with CIN (Luesley et_
al, 1987).
HPV 16 DNA is also found in vaginal and vulvar intra¬
epithelial neoplasia (McCance et al, 1985b), in invasive vulvar
carcinoma (McCance, 1986) and in bowenoid papulosis, a generally
benign in situ lesion found on the vulva and penis (Ikenberg et al,
1983; Gross et al, 1985).
Penile carcinoma is rare in Europe and North America and tends
to occur in old age (over 60 years) but is much more common in
certain African countries and in central and South America
(McCance, 1986). In one study of penile carcinomas in patients
from Brazil, HPV 16 was found in 50% of lesions (McCance et al,
1986a). The patients were much younger (33-55 years) than in
countries where there is a low incidence of penile carcinoma.
Other factors must contribute to this high incidence, since penile
cancer is rare in other countries where female genital cancers are
common.
Other areas such as the anal canal have been shown to be
infected with HPVs. HPV16 has been found in anal intraepithelial
neoplasias (McCance et al, 1985b) and in invasive diseases in this
area (Beckman et al, 1985). Although HPV 16 is associated with
premalignant lesions throughout the female genital tract,
malignancy occurs most often on the cervix. This may be due to
the particular susceptibility of the cervical TZ, as discussed
above.
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The papillomavirus genome is in a free and unintegrated state
in benign condylomata and in premalignant lesions of the cervix,
vulva and penis (McCance, 1986). In malignant lesions of the
cervix, vulva and penis, however, the HPV genome appears to be
integrated in the majority of cases. Junction fragments containing
HPV 16 and human DNA sequences have been cloned to prove that the
viral DNA is integrated into chromosomes (Durst et al, 1985).
Integration occurs at several random sites in the host chromosome
either as single copies or as random repeats (Durst et al, 1985;
Lehn et al, 1985). The pattern of random integration in tumours
suggests that the site of integration is not important. There
does, however, appear to be some specificity as to the break site
in the HPV 16 genome, with interruptions occurring in 4 of 5
tumours in one series in the El or E2 open reading frames (ORF)
(Lehn et al, 1985).
Some tumours contain free episomal DNA in addition to
integrated DNA, and at least one cervical tumour has been found to
contain only free DNA with no detectable integrated sequences
(McCance et al, 1985a).
Several cell lines grown from cervical cancers harbour either
integrated HPV 16 or HPV 18 DNA sequences (Schwarz et al, 1985; Yee
et al, 1985) suggesting that integration is more than a co¬
incidental event. Most of the cell lines contain multiple copies
of either HPV16 or HPV 18 and in three lines, HeLa, C4-1 and SW
756, the breakpoint in the viral genome for integration occurs in
the region of the E1/E2 ORFs (Schwarz et al, 1985). These three
cell lines also contain transcripts from the E6/E7 ORFs and a
product of the HPV 18 E6 region has been identified in HeLa and
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SiHa cells (Banks et al, 1987). It may be relevant that the E6
ORF of bovine papillomavirus (BPV) type 1 is important in the
transformation of mouse cells (Yang et al, 1985).
These data suggest that HPV may have a more important role in
the aetiology of cervical carcinoma than HSV. There have been
recent reports, however, of the isolation of HPV6 from between 11%
(Wickenden et al, 1985) and 50% (Schneider et al, 1987) and of HPV
16 from between 9% (Toon et al, 1986) and 38% (Cox et al, 1986) of
apparently normal cervices suggesting that HPV may be a very common
commensal. Cox et al (1986) found no evidence of HPV DNA
integration in normal cervices and this may be significant,
iv) Extra-genital neoplasia
In man, malignant transformation of HPV induced lesions can be
seen in the rare inherited condition, epidermodysplasia
verruciformis (EV). Most patients suffering from this condition
have a defect in cell mediated immunity (Prawer et al, 1977).
They suffer from multiple skin warts caused by EV specific HPVs
(types 5,8,9,12,14, 15,17 and 19 to 25) as well as HPVs 3 and 20
which induce plane warts in the general population (Jablonska and
Orth, 1985). Approximately one-third of EV patients develop
multiple skin cancers which are usually invasive squamous cell
carcinomas and which usually occur at light exposed sites.
Hybridisation experiments have demonstrated the extrachromosomal
persistence of HPV5 and HPV5 related (HPV 8 and 14) DNA in
carcinomas (Ostrow et al, 1982). This contrasts with the greater
variety of HPV types found in the benign lesions of the same
patients, suggesting that HPV 5 related types have a higher
oncogenic potential than other EV specific HPVs, or than the HPV
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types which are common to EV and to the general population.
Renal transplant recipients are immunosuppressed with agents
such as prednisolone and azathioprine and experience skin warts
more frequently than the general population (Van der Leest et al,
1987). Like EV patients, they harbour HPVs of a much wider range of
types than is generally found (Rudlinger et al, 1986; Van der
Leest et al, 1987). They also have a higher than expected
incidence of skin tumours, especially squamous cell carcinoma, and
it is thought that some of these tumours are due to the malignant
transformation of HPV induced lesions (Rudlinger et al, 1986).
HPV DNA, including HPV 5 DNA which was previously thought to be
found only in EV, has been isolated from malignant skin tumours in
these patients (Lutzner et al, 1983).
The cancer incidence in renal transplant recipients is
proportional to the duration of immunosuppression (Hardie et al,
1980) and to the duration of sunlight exposure (Boyle et al, 1984),
suggesting that there are similarities between this group of
patients and those suffering from EV.
Squamous cell carcinomas of the skin from normal individuals
have been negative for HPV DNA when tested with known types
(McCance, 1986)
HPV causes laryngeal papillomatosis in infants and young
children (Mounts and Kashima, 1984). Children probably acquire
the infection from the maternal genital tract during vaginal
delivery while accumulating evidence suggests that some adult
laryngeal warts are transmitted by oro-genital sexual practices
(Anon, 1984). The lesions are benign but malignant conversion
occurs at a high frequency in patients treated with radiation
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(Gissman et al, 1983). Smoking is also believed to be a possible
co-factor in the malignant conversion of the lesions (Brescia et_
al, 1986). Carcinomas of the oral cavity including the tongue
(Ostrow et al, 1987; Lookingbill et al, 1987) and buccal mucosa
are associated with HPV2, 11 and 16 while hyperplasia of the buccal
mucosa (the Heck lesion) is associated with HPV 6 and 13 (Pfister
et al, 1983; De Villiers et al, 1986). HPV DNA has been isolated
from oesophageal carcinomas (Hille et al, 1986) and from carcinomas
of the lung and caecum (Ostrow et al, 1987). A recent publication
from Maitland et al (1987), however, reports the isolation of HPV
16 DNA from 5/12 (42%) specimens of normal oral mucosa including
one specimen in which the viral DNA was integrated. A similar
proportion (46%) of oral tumours analysed contained HPV 16 DNA.
This data suggests that HPV 16 may be a normal commensal in the
mouth and that integration may not be as significant an event as
had hitherto been believed.
Thus, HPVs have been associated with benign and malignant
disease at various epithelial sites. For cancers apart from
genital and laryngeal lesions, however, the number of HPV positive
tumours is small,
v) Animal models
It is known that other papillomavirus induced lesions, under
certain circumstances, undergo malignant change. The bovine
papilloma virus (BPV) type 4 induces oesophageal papillomas in
cattle. In cattle which eat bracken fern (which contains
carcinogens and immunosuppressants) the papillomas sometimes
progress to squamous cell carcinomas (Campo and Jarrett, 1987).
The sequence of events involved in the conversion of a papilloma to
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a carcinoma can also be examined in domestic rabbits experimentally
infected with the Shope or cotton-tail rabbit papillomavirus (SPV)
(Kreider and Bartlett, 1985). It is not known whether the SPV
genome plays an essential role in malignant transformation but it
is present in carcinomas (Stevens and Wettstein, 1979) as are
SPV-encoded antigens (Mellors, 1960) and it is known that the
probability of carcinomatous change is directly proportional to the
dose of SPV used to initiate the papillomas (Rous et al, 1936).
c) Other viruses
Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are herpes
viruses which are associated with human malignancies, and which are
shed from the female genital tract. So far there is no firm
evidence to implicate CMV in cervical tumorigenesis. The
literature concerning CMV and carcinogenesis is reviewed by Rapp
(1984). EBV has only recently attracted attention as a possible
aetiological agent in cervical cancer as its shedding from the
cervix was not previously appreciated. Its possible role is
discussed in a recent Lancet editorial (Anon, 1986).
d) Other infectious agents
Chlamydia, Trichomonas vaginalis and Gardnerella vaginalis are
all known to be transmitted by sexual intercourse and have
therefore been investigated as possible carcinogenic agents. A
recent study found no evidence to support the hypothesis that
Chlamydia is important either alone or in combination with HPV in
causing CIN (Syrjanen et al, 1986). There is little recent work
on Trichomonas vaginalis but studies published suggest that it is
not an important factor (Thomas and Anderson, 1974). Gardnerella
vaginalis, like EBV, has attracted attention only recently (see
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Gonzalez-Falco et al, 1986).
3. Smoking
Cigarette smoking is known to be a risk factor for the
development of malignant tumours not only in the lung, but
elsewhere in the body. It was discovered recently that nicotine
and other mutagenic derivatives of cigarette smoke can be isolated
from the cervical mucus of smokers (Sasson et al, 1985) and it is
possible that these derivatives have a direct carcinogenic effect
upon epithelial cells within the cervical transformation zone. In
addition, smokers are known to have a variety of alterations in
immune function (see below) so that they may be less efficient at
detecting malignant cells and at mounting an immune response.
Epidemiological studies performed over the last 15 years
appear to show a clear link between smoking and cervical neoplasia.
Some of these studies are reviewed by Winkelstein et al (1984) who
include four studies in which the association persists after
adjustment for various potentially confounding factors such as
sexual history. Since Winkelstein's review four further studies
have been published which confirm the association between smoking
and cervical neoplasia (Clarke et al, 1985; Greenberg et al, 1985;
La Vecchia et al, 1986; Hellberg et al, 1986). Apart from
Greenberg et al (1985) all investigators took a sexual history from
patients and controls, and all found that smoking remained a
significant risk factor after adjustment for this. It is true
that it is easier to publish work demonstrating a positive
association than work showing no association but nevertheless
epidemiological studies would appear to indicate that smoking is a
significant factor in the aetiology of cervical neoplasia.
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4. The combined oral contraceptive pill (OCP)
The role of the OCP in the aetiology of cervical neoplasia is,
like that of smoking, still a matter for debate. In the UK deaths
from cervical cancer among women under the age of 35 have increased
over the last 20 years, while there has been a progressive decrease
in mortality from this disease in women over 50 (Doll, 1985).
This increase in mortality in young women has coincided with the
introduction of the OCP as a popular contraceptive method and some
authors argue that the two observations are causally related (Doll,
1985).
It is known that the OCP can induce cervical cancer in mice
(Thomas, 1972) and the reported association of various degrees of
cervical neoplasia with endometrial hyperplasia has suggested for
some time that cervical cancer may be oestrogen dependent. Like
smokers OCP users are known to have alterations in immune function
(see below) and it has been suggested that the OCP may be a risk
factor for the development of cervical neoplasia by virtue of its
effects on the immune system (MacDonald, 1982). Pater et al (1988)
have shown that addition of glucocorticosteroids to culture medium
increases the transforming ability of HPV 16 in cooperation with an
activated ras oncogene, and suggest that this evidence implies a
causal role for oral contraceptives in the aetiology of cervical
neoplasia.
There have been two major reviews of studies investigating the
role of the OCP in cervical neoplasia published recently
(Francheschi et al, 1986; Piper, 1985). Francheschi et al (1986)
examined epidemiological evidence concerning the OCP through pooled
computations of relative risks emerging from 21 studies of three
categories: studies based on routine cytological screening
programmes, case control investigations and prospective studies.
The pooled estimates of relative risk for ever versus never use of
the OCP were broadly similar and slightly above unity (1.4 from
screening programmes, 1.1 from case control and 1.4 from
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prospective studies). The risk increased with duration of use.
When allowance was made for indicators of sexual habits a
noticeable decrease in the excess risk was evident. Francheschi et
al (1986) stress the point made in the last section in relation to
smoking, i.e. that it is easier to publish positive studies than
investigations showing no association. There are several reasons
why the OCP may appear to confer higher risk than is really the
case. OCP users tend to visit a doctor more frequently than
non-users, thus making opportunistic screening, and detection of
asymptomatic cases, more likely. If women using barrier methods
of contraception are included in the control group the rate of
cervical neoplasia in this group will be brought down, as these
methods may confer specific protection against cervical
malignancies (Richardson and Lyon, 1981; Vessey et al, 1983).
Similarly if women using no contraception are included as controls
and no adjustment is made for sexual history the cervical neoplasia
rate in the control group will be artifically low, as these women
are less likely to be sexually active than OCP users.
Two recent studies, not reviewed by Francheschi et al, have
questioned the role of the OCP in the aetiology of cervical
neoplasia. Hellberg et al (1986) found that the association
between long term (over 5 years) OCP use and CIN disappeared when
adjustment was made for smoking and sexual history, and if users of
barrier methods were excluded from the control group. Clarke et_
al (1985) also adjusted for smoking and sexual history and again
found that the association between OCP use and CIN then disappeared.
Stern et al (1977) suggested that the OCP may be implicated
not as an initiator but as a promoter and may accelerate
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progression from pre-invasive to invasive disease. Two recent
prospective studies (Vessey et al, 1983 and Andolsek et al, 1983)
lend support to this theory. Vessey et al compared 6838 OCP users
with 3154 women using an intrauterine contraceptive device (IUCD).
A sexual history was taken from a sub-section from each group and
the two groups were found to be very similar with regard to sexual
variables. Thirteen cases of invasive cervical carcinoma were
identified during the trial, and these were all in OCP users.
Andolsek et al (1983) report that all the cases of invasive
carcinoma identified in their trial were also in OCP users.
The evidence concerning the OCP is therefore much less
persuasive than that concerning smoking. Further prospective
trials in which women using modern low dose OCPs are compared with
IUCD users and both groups are questioned about sexual factors and
about smoking are necessary before we can draw any firm
conclusions. The findings of Vessey et al (1983) and Andolsek et al
(1983) concerning invasive carcinoma are worrying, however.
Perhaps clinicians should consider advising women who are thought
to be at high risk of developing invasive disease (because of




Until recently the skin and other epithelia were considered
immunologically inert, only able to protect the body from infection
and other environmental hazards by providing a physical barrier.
Recent advances in technology including the development of
monoclonal antibodies (Mabs) have permitted detailed examination of
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the immunology of skin and have revealed that lymphocytes and
antigen presenting cells (APC) are continuously circulating between
the epithelial surface and local lymph nodes. Streilein (1978)
has proposed that the entire unit be named SALT (skin associated
lymphoid tissue) in analogy with GALT (gut associated lymphoid
tissue). Bos et al (1987) have argued that the two systems are
not analogous, because the evidence for co-operation between
lymphocytes and keratinocytes is less strong than the evidence for
co-operation between lymphocytes and epithelial cells lining the
gastrointestinal tract. It is generally accepted, however, that
foreign antigen breaching the epithelial surface is picked up by
APC and presented to T lymphocytes within the epithelium, or in the
draining node. As a result T helper cell proliferation occurs with
the possible generation of cytotoxic T cells, specific for that
antigen. Alternatively free antigen may pass straight to the node
to be picked up by APCs there, leading to a similar immune response,
b) Major histocompatibility complex (MHC) class II antigens
The genes of the MHC are found on chromosome 6 in humans and
code for three classes of antigens (see figure 5). They control
the expression of alloantigens present on the surface of all
nucleated cells. These are the human leucocyte antigen (HLA)-A
and -B or class 1 antigens associated with transplant rejection
(Svejgaard et al, 1979). The second series of genes of the human
MHC controls the expression of alloantigens with a restricted
tissue distribution. These are the HLA-D or class II antigens and
were originally defined by the mixed lymphocyte reaction (MLR)
which is the ability to induce a proliferative lymphocyte response
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The final locus in the MHC (HLA-C or class III) controls the
production of certain serum complement factors.
Studies on the MHC have been carried out extensively in mice
(McDevitt et al, 1976) where inbred and congenic strains are
available. The murine equivalent of the human HLA-D region is the
Ir (immune response) region. It controls several important immune
phenomena in addition to the MLR and including the ability to
respond to certain types of antigen, the graft versus host
reaction, T-B cell co-operation, T cell-macrophage co-operation and
antigen presentation (Rowden, 1981). Human HLA-D or class II
antigens are heterodimeric glycoproteins (Klareskog et al, 1977)
expressed on the surface of B lymphocytes, macrophages, Langerhans
cells, and, under certain circumstances, on activated T lymphocytes
and some epithelial cells (Wiman et al, 1978). The number of
different class II antigens expressed by a single cell varies,
depending on whether the cell is homozygous or heterozygous as
regards the HLA-D region. All class II molecules are composed of
one c* and one g chain, which have very similar structures and are
believed to share a common ancestor. Most, if not all, class II
genes appear to be localised to three well defined loci known as
HLA-DP, -DQ and -DR.
Expression of MHC class II products can be modulated by T cell
products. It was originally demonstrated that low levels of class
II antigen expression could be augmented by T cell factors present
in crude lymphokine preparations (Steeg et al, 1982). The
inducing factor has been shown subsequently to be gamma interferon
and the observations have been extended to human monocytes (Gonwa
and Stobo, 1984) and to Langerhans cells (Berman et al, 1985).
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Expression of MHC class II antigens is not, however, confined
to traditional cellular components of the immune system.
Initially it was noted that several human tumour cell lines of
non-bone marrow origin also expressed class II antigens (notably
melanoma cells) and that this expression could be increased by
gamma interferon (Basham and Merigan, 1983). It was then shown
that normal cultured human endothelial cells, as well as human
dermal fibroblasts, could be induced to express HLA-DR, and that
this effect was mediated by activated T cell products or by gamma
interferon (Pober et al, 1983a; Collins et al, 1984).
In fact recent studies have demonstrated that cultured cells
from virtually every organ and every embryonic germ layer can be
induced to express HLA-DR in response to gamma interferon, although
a few tumour cell lines such as teratocarcinomas and neuroblastomas
are exceptions (Houghton et al, 1984).
The expression of MHC class II antigens by normal and diseased
tissue has been extensively reviewed (Natali et al, 1981; Daar et_
al, 1984; Forsum et al, 1985). It has been proposed that in
inflammatory conditions class II expression is induced by
lymphokines produced by infiltrating lymphocytes (Lampert, 1984;
Aubock et al., 1986) but the mechanisms controlling class II
expression by healthy tissue (Morris et al, 1985; Carr et al,
1986) are unclear. It has been suggested that class II expression
may be under the influence of hormones including sex hormones
(Klareskog et al, 1980; Tabibzadeh et al, 1986a) and thyroid
stimulating hormone (Todd et al, 1986).
The role of class II expression by non-lymphoid cells is
unresolved. Comparison of HLA-DR antigens of autologous melanoma
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and lymphoblastoid cell lines reveals differences in glycosylation,
but not in protein structure (Alexander et al, 1984). The ability
of HLA-DR positive melanoma and other non-lymphoid cells to
function as accessory cells in immune responses may be limited by
the nature of the induced class II antigens, as well as by their
ability to produce interleukin 1 which is required to maintain (or
support) T cell responses. It is of interest that it has been
shown that HLA-DR positive cultured melanoma cells from early but
not late disease are able to stimulate autologous lymphocytes
(Guerry et al, 1984).
It has also been shown that the HLA-DR antigen induced on
human umbilical vein endothelium (HUVE) and human dermal
fibroblasts (HDF) does function in immune responses in a variety of
ways. HLA-DR antigens on HUVE and HDF are recognised by HLA-DR
restricted cytotoxic T cells with subsequent target cell cytolysis
(Pober et al, 1983b) and HLA-DR positive human thyroid cells can
present nominal antigen to cloned T cells (Londei et al, 1984).
c) The Langerhans cell
The major APC within squamous epithelium is the Langerhans
cell (LC) (figure 6). It was first described by Paul Langerhans
in 1868 who believed it to be an intraepidermal sensory element,
because of its long dendritic processes and staining properties.
It is now known that LC belong to the macrophage/monocyte lineage
(although they are poorly phagocytic) (Wolff and Schriener, 1970),
possess Fc receptors and C3 receptors (Stingl et al, 1977) and
express MHC class II antigens (Rowden et al, 1977). LC are
present in all stratified squamous epithelium possessing the
ability to keratinise and appear in epithelium undergoing squamous
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Figure 6 DAK0-T6 staining of Langerhans cells





metaplasia (Rowden, 1981). They were first demonstrated in human
cervix in 1968 (Hackermann et al, 1968; Younes et al, 1968). In
skin the cells are usually seen in the epidermis in a suprabasal
position (Hunter, 1984) and can be seen crossing the
dermal-epidermal junction, in the superficial dermis and within
dermal lymphatic vessels (Wolff and Stingl, 1983; Rowden, 1981).
Some dendritic cells, usually seen in the basal layer of the
epidermis, have been called indeterminate cells because they appear
similar to LC and melanocytes but contain neither the granules
characteristic of LC nor melanosomes. The study of serial
sections and surface antigens (Rowden et al, 1979) of these cells
suggests that most are probably LC precursors,
i) Methods of identification
LC can be identified by electron microscopy (EM) where they
are characterised by a variety of histochemical and
immuno-histochemical means. The cell is characterised on EM by
the possession of Birbeck granules, the purpose of which is unknown
(Birbeck et al, 1961).
Histochemical stains include gold (Juhlin and Shelley, 1977),
osmium (Rodriguez and Caorsi, 1978) and adenosine triphosphate
(Wolff and Winkelmann, 1967). These stains have not proved
sufficiently specific for light microscopy in the hands of most
workers and will not be discussed further.
The most commonly used marker for LC is currently T6,
thymocyte antigen. Anti T6 reacts with 70% of thymocytes but not
with peripheral T lymphocytes (Bhan et al, 1980; Reinherz et al,
1980) and has been shown by an immunoperoxidase EM technique to
label intraepidermal LC (Murphy et al, 1981). Indeterminate cells
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within the epidermis are also T6 positive (Murphy et al, 1982). T6
antigen on the surface of thymocytes has been partially
characterised. It is a 49,000 dalton glycoprotein and is
associated with microglobulin (Terhorst et al, 1981). The
character of the antigen on LC is unknown at present.
Mabs to MHC class II antigens can also be used to identify
LCs. However, MHC class II antigen expression by LC is known to
be variable (Dezutter-Dambuyant et al, 1985) in response to such
stimuli as ultra-violet irradiation (Aberer et al, 1981) so that T6
positive LC may sometimes appear MHC class II negative (Muhlbauer
et al, 1982 and Harrist et al, 1983). There are also other MHC
class II positive cells within squamous epithelium which may be
confused with LC. These include B lymphocytes, activated T
lymphocytes and, in some cases, keratinocytes (Carr et al, 1986) as
discussed above,
ii) Functional properties
In 1976 Shelley and Juhlin found that LC had an affinity for
common external contact sensitisers including metal ions. Stingl
et al (1980a) then demonstrated that guinea pig epidermal LC could
replace macrophages in their capacity to induce antigen specific T
cell activation. Braathen and Thorsby (1980) were able to show
the same phenomenon in man.
There is now considerable evidence that specially functioning
cells play an essential role in the presentation of antigens to
effector lymphocytes in many immune responses such as antibody
production, antigen and mitogen induced T cell proliferation and
cytotoxic T cell induction (for review see Katz et al, 1985) and
recent studies implicate dendritic cells rather than macrophages
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Klinkert et al, 1982). It has been shown with respect to at least
one antigen (purified protein derivative) that LC are superior to
blood derived dendritic cells at inducing antigen specific T cell
proliferation (Bjercke et al, 1985). LC are believed to play an
important role in immunosurveillance against tumours and viral
infections of squamous epithelium. These functions will be
discussed below.
For T cell responses to be induced the antigen presenting cell
(APC) and T cell must be histocompatible, sharing the same MHC
class II molecules (Braathen and Thorsby, 1982). Considerable
knowledge has gathered with regard to the mechanism(s) by which APC
"process" and present antigen to T cells. Studies from various
laboratories demonstrate that antigen presentation by macrophages
and B lymphocyte tumour cells can be inhibited by chemicals
interfering with lysosomal transport and function (Katz et al,
1985). These studies indicate that large molecules (i.e.
ovalbumin, cytochrome and myoglobulin) must be digested so that the
smaller proteolytically cleaved molecules may be presented to T
cells (Streicher et al, 1984). Glutaraldehyde fixed APC which are
unable to present intact ovalbumin to T cells are able to present an
immunogenic 17 residue peptide, thus bypassing the lysosomal
"processing " step. In skin it it not known whether LC process
antigen as well as presenting it or whether keratinocytes process
it before presentation by LC.
There are two hypotheses concerning the way in which T cells
recognise antigen and MHC products on cell membranes (Roitt, 1985)
[see figure 7].











Figure 7 Antigen presentation : 3 models
(modified from Roitt etal., 1985)
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the antigen are recognised by separate receptor molecules on the
lymphocyte surface.
The associative recognition hypothesis (which is currently
more popular) proposes that antigen, possibly modified by
antigen-presenting cells, associates with the MHC product, and is
recognised by a single T cell receptor. This hypothesis has been
modified to give the altered self hypothesis according to which the
self-MHC on the APC is somehow modified by the presence of antigen.
It is proposed that a single T cell receptor recognises both
antigen and altered self. The activation of T cells is thought to
occur in three phases. Following binding of the T cell to the APC
an unknown factor from the T cell induces the APC to produce
interleukin-1. This, in association with antigen stimulation,
induces interleukin-2 receptors on the T cells and stimulates T
cells to release interleukin-2 which drives antigen- activated
cells into proliferation,
d) The T lymphocyte
In normal squamous epithelium T lymphocytes exceed B
lymphocytes in number. Normal skin (Bos et al, 1987), gastro¬
intestinal mucosa (Selby et al, 1983) and epithelium lining the
male genital tract (Eldemiry et al, 1985) contain predominantly T
suppressor (CD8 positive) cells. It is argued that a predominance
of suppressor cells within the gastrointestinal mucosa leads to a
state of tolerance of oral antigens (Mowat, 1987) while in the male
genital tract the presence of these cells is believed to prevent
the development of an immune response to autoantigens present on
spermatozoa (Eldemiry et al, 1985). In the skin it is believed
that CD8 positive cytotoxic/suppressor cells may recognise altered
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self and destroy potentially malignant cells (Streilein, 1978).
The immune response to tumours
It has been believed for many years that one function of the
immune system was to provide "immunosurveillance" against tumours
(Thomas, 1959; Burnett, 1970). This was first challenged in the
1970s (Stutman, 1978) when it was discovered that T lymphocytes had
another role. It was then argued that the increased incidence of
malignant disease in patients with inherited disorders of immunity
might be due to some other genetic abnormality rather than to their
immunodeficiency (Kirchner, 1984). In addition it has been argued
that the increased incidence of malignancy in patients with
secondary immunosuppression such as lymphoma patients may be due to
the mutagenic effects of the chemotherapeutic agents employed in
their treatment (Anon, 1985). A collaborative UK-Australasian
study (Kinlen et al, 1979) of 3823 renal transplant recipients and
1349 others who had received azathioprine, cyclophosphamide or
chlorambucil found that only lymphoreticular and cutaneous
malignancies were increased in incidence. Three squamous cell
carcinomas of vulva were included in the "cutaneous malignancy"
category and cervical CIS was excluded. The authors argue that a
mutagenic effect of the agents used is unlikely as there was no
dose effect and a constant risk was observed from the time of first
exposure. It has been argued on the basis of this survey that
immunosurveillance against tumours may be confined to the skin and
to other components of the immune system (Mitchison and Kinlen,
1980).
Iochim (1976) investigated the stromal reaction in CIS of the
cervix, bronchus, vagina and breast and found large collections of
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lymphocytes just below the basement membrane. He noted a greater
cellular reaction in precancerous and early cancerous lesions than
in advanced metastatic lesions and argued that this was evidence of
an immune response to tumour cells.
Husby et al (1976) and Ferguson et al (1985) have similarly
demonstrated increased numbers of T lymphocytes around and within
malignant tumours. Viae et al (1977) extracted lymphocytes from
basal cell carcinomas (described as "weakly malignant") and
superficial spreading melanomas (described as "highly malignant").
Basal cell carcinomas contained more T lymphocytes and plasma cells
than did melanomas.
Ferguson et al (1985) examined tumours of the female genital
tract and found that infiltrating T cells were predominantly CD8
positive. Bussy-Fernandez et al (1983) reported a similar
predominance in malignant skin tumours, whereas Gatter et al (1984)
reported that T cells surrounding malignant skin tumours were
predominantly of the CD4 (helper/inducer) phenotype. It would be
of interest to discover the subsequent outcome in these patients.
It is possible that the predominance of a particular T cell subset
within a tumour infiltrate may be related to the prognosis.
It is postulated that LC play a role in the putative immuno-
surveillance system by virtue of their situation in the "front
line" of the body's defences (Streilein and Bergstresser, 1980).
Studies of the effects of ultraviolet (UV) irradiation on the skin
would support this hypothesis. UV irradiation plays an important
part in the induction of neoplasms of both keratinocytes and
melanocytes (Rowden, 1981) as well as reducing the numbers of
cutaneous LC (Stingl et al, 1980b), altering LC morphology and
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antigen presenting function (Perry and Greene, 1982), and reducing
MHC class II expression by LC (Aberer et al, 1981). It is not
known whether UV irradiation destroys the LC or causes it to
migrate out of the epidermis. Gurish et al (1982) have reported
an increase in APC activity in draining lymph nodes following UV
irradiation suggesting that LC migrate away from the epidermis,
rather than being killed.
Mice exposed to UV irradiation develop T suppressor cells
which prevent immunological rejection of the highly antigenic skin
cancers induced by UV irradiation (Fisher and Kripke, 1982). If
mice are immunised with epidermal cells that have been exposed In
vitro to UV irradiation prior to their coupling with antigen the T
suppressor cell pathway is activated (Kripke and Morison, 1985)
suggesting that activation of the T suppressor cell pathway and
consequent failure to reject tumours results from a direct effect
of UV irradiation on APC.
When hamster buccal mucosa is treated with a carcinogenic
agent (7,12 dimethylbenzanthracene) LC are reduced in number and
their morphology is altered (Schwartz et al, 1981). This may
contribute to the carcinogenic effect of this agent.
Studies of LC in human tumours have shown that LC numbers are
greater in benign lesions (excluding those induced by HPV) and well
differentiated tumours than in poorly differentiated tumours (Lisi,
1973; Gatter et al, 1984; Furukawa et al, 1984).
The effects of smoking and oral contraceptive use on the immune
system
It has been suggested that the apparently increased risk of
CIN in smokers and OCP users may be due to the effects of these
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agents upon the immune system, and on viral and/or tumour immuno-
surveillance (MacDonald, 1982).
Smokers have been shown to have low circulating natural killer
cell activity (Ferson et al, 1979 and Hughes et al, 1985) and low
serum immunoglobulin levels (Ferson et al, 1979). Heavy smokers
have also been shown to have a reduced percentage of circulating
CD4 positive (helper) T cells and an increased percentage and total
number of CD8 positive (cytotoxic/suppressor) T cells (Miller et_
al, 1982). Of particular interest is the recent report from Barton
et al (1988) of a significant reduction in LC numbers in both normal
and neoplastic cervical epithelium of smokers, when compared with
non-smokers.
Progesterone has an immunosuppressive effect which is thought
to be partly responsible for maternal tolerance of the fetus
(Munroe, 1971). Women using the combined oral contraceptive pill
have been shown to have an impairment of peripheral blood
lymphocyte proliferation in response to a non-specific mitogen
(phytohaemagglutinin) (Barnes et al, 1974; Pater et al, 1988).
The Immune response to the human papillomavirus
a) General
The role of the systemic immune response in resistance to HPV
infections and in regression of warts is not well understood.
Clinical observations, however, suggest that cell-mediated immunity
(CMI) is of more importance than humoral immunity. Studies of
patients with primary predominantly humoral immunodeficiencies do
not reveal a high incidence of warts, except in the common variable
form of hypogammaglobulinaemia. One third of the patients
suffering from this disease also have an alteration in T lymphocyte
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function (Kienzler, 1985). In secondary humoral
immunodeficiencies such as multiple myeloma the incidence of warts
is not higher than in a control population (Morison, 1975a).
Some workers regard HPV antibodies to be a consequence of wart
regression rather than a factor contributing towards regression.
It has been shown in some studies that HPV antibodies only occur
during or after treatment (Genner, 1971 and Eriksen, 1980) and it
is well recognised that antibodies do not protect against
reinfection (Cubie, 1972). Pyrhonen and Johansson (1975) examined
a group of patients with regressing warts and identified several
patients who underwent a rapid spontaneous cure without developing
demonstrable antibodies.
The above data suggest that antibodies do not have a
significant role in causing regression of warts or in preventing
reinfection although it has been suggested that they may reduce
spread of infection by neutralising HPV once liberated (Kienzler,
1985). It is important to remember that many of the early studies
employed complement fixation to detect antibodies. This is a
relatively insensitive method and is particularly poor at detecting
IgM. It was also thought until fairly recently that all
HPV-induced lesions were due to a single virus. Now that the
antigenic heterogeneity of HPVs has been established it will be
necessary to repeat antibody studies using distinct HPV antigens in
patients with strictly defined warts, as has been reported in
recent studies (Kienzler et al, 1983; Cubie and Norval, 1988).
Patients with specific CMI deficiencies on the other hand, do
have an increased incidence of warts. Epidermodysplasia
verruciformis has been discussed above but other examples are
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patients with Hodgkin's disease (Morison, 1975a) and Fanconi's
anaemia (Johansson et al, 1982). In 1974 Brodersen et al reported
that children in whom skin warts develop are more likely to be
anergic to purified protein derivative.
Specific anti-HPV CMI has been tested in patients with warts
using in vivo and in vitro methods. Thivolet et al (1982)
performed intradermal skin testing using inactivated viral
particles from plantar warts and found that significantly more
patients with current or past warts had a positive skin test than
controls, and that a higher response was obtained in patients with
regressing or past warts than in controls.
In vitro tests such as the leucocyte migration inhibition
(LMI) test and lymphocyte transformation test (LTT) have been used
to obtain similar results. Morison (1974) using a LMI test showed
that few patients gave a positive response while they had skin
warts but that many were positive just after resolution of their
warts. Similarly using a LTT stimulation was greatest in those who
had had warts in the recent past (Ivanyi and Morison, 1976; Lee
and Eisinger, 1976). Weak or negative responses were obtained in
those patients who had warts of long duration (Morison, 1975b).
Obalek et al (1980) found non-specific CMI as assessed by
response to phytohaemagglutinin (PHA) to be markedly reduced in
patients with flat warts as well as in EV patients, although there
was only a slight defect in patients with common warts. Response
was almost normal in patients with plantar and genital warts. In
the same study they found that the percentage of E rosetting T
lymphocytes was reduced in patients with common, flat and plantar
warts while Chretien et al (1978) report a decreased percentage of
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T lymphocytes and an alteration in T cell morphology in patients
with previous and current warts. In a more recent study Carson et_
al (1986) found a reduction in the CD4+ : CD8+ T cell ratio in
patients with skin warts.
b The immune response to HPV in patients with genital warts and CIN
These patients have been studied in an attempt to identify an
abnormality in their immune response to HPV which might somehow
permit progression to neoplasia in a manner analogous to that seen
in EV. It is not currently possible to study the specific humoral
or cell mediated immunity to the HPV types associated with genital
lesions as, for reasons discussed above, viral antigen has to be
prepared from HPV associated lesions, and genital warts contain too
little viral antigen to allow the development of satisfactory
serological tests (Gissmann and Gross, 1985).
Baird (1983) reported higher levels of antibody to detergent
disrupted BPV antigen in women with anogenital warts, with CIN and
especially with invasive cervical carcinoma than in controls but a
more recent study of patients attending a Colposcopy Clinic found
that anti-BPV and anti-HPV antibody levels correlated with a
history of skin warts and were unrelated to the presence of CIN or
of genital HPV infection (Cubie and Norval, 1988). Baird (1983)
does not provide details of skin wart history.
Seski et al (1978) studied a group of women with recalcitrant
genital warts and reported a significant reduction in CMI. This
finding was confirmed by Carson et al, 1986. A similar study of
patients with CIN (Neill, 1984) showed, however, normal
responsiveness to PHA, concanavalin A and pokeweed mitogen, apart
from a reduced response to PHA in patients with CIS.
49.
c) The local immune response to HPV
Interest in the local immune response was stimulated by the
observation that plane or flat warts (caused by HPV 3) regress
spontaneously following inflammation (Tagami et al, 1977). Biopsies
taken from regressing flat warts show a massive mononuclear
infiltrate (Tagami et al, 1980) and if explants from these lesions
are cultured in vitro mononuclear cells can be seen attacking the
wart derived epidermal cells. Broderson and Genner (1973) and
Kossard et al (1980) describe a minimal or absent inflammatory
infiltrate in cutaneous common warts (caused by HPV 2) showing
signs of involution. Nevertheless, HPVs cause a localised
epithelial infection and the local immune response must be of
central importance in the pathogenesis of these lesions.
Characterisation of the cells involved in the local response has
been made more feasible in recent years by the availability of
monoclonal antibodies.
i) Langerhans cells in HPV induced lesions and in cervical
neoplasia
The literature on LCs is very sparse in the area of their
possible role as sentinels against viral infection. Nagao et al
(1976) studied sites of vaccinia virus inoculation and
demonstrated virus in the phagolysosomes of LCs on the developing
blister roofs. Intradermal injection of cytomegalovirus also
leads to an accumulation of virions in LCs, both in the epidermis
overlying the injection site and in the dermis (Rowden, 1981).
The observations of Oguchi et al (1981) that LC around regressing
plane warts showed evidence of activation led other workers to
examine LC in HPV induced lesions more closely. Most workers have
50.
found LC to be reduced in number around skin and genital warts and
have noted an alteration in LC morphology including a loss of
dendritic processes and a rounding of the cell body (Morris et al,
1983; Gatter et al, 1984; Chardonnet et al, 1986; Tay et al,
1987a). Two groups, however, report an increase in LC numbers in
genital although not in skin warts (Vayrynen et al, 1984; Bhawan
et al, 1986). However, Vayrynen et al (1984) compared their
patients with current genital HPV lesions with "controls" who had
treated or regressed HPV lesions and who cannot be regarded as true
normal controls. Bhawan et al (1986) report a decrease in LC
numbers in skin warts but an increase in three condylomata
acuminatum (exact site not given). LC numbers were assessed
purely by a visual estimate which is not considered a very reliable
method of enumeration (De Jong et al, 1986).
In CIN, in contrast, most workers have found LC to be
increased in number within the abnormal epithelium and to display a
similar morphological alteration as seen in HPV asociated lesions
(Morris et al, 1983; McArdle and Muller, 1986). Interestingly,
Caorsi and Figueroa (1986) in an electron microscopic study found
that LC were increased in number in CIN but, in contrast to other
studies, found an increase in the more ramified types of LC in
CIN, with the most ramified cells being more frequent in most
severe lesions.
Vayrynen et al (1984) found LC numbers to be increased
relative to normal in CIN I but decreased in CIN III, while
Syrjanen et al (1984) in a prospective study found that LC counts
were lower in patients whose disease progressed than in those whose
disease regressed. Tay et al (1987a) in a recent study enumerated
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LC within cervical HPV lesions and CIN using a variety of markers
(adenosine triphosphatase, T6, HLA-DR and S100). Positive cells
2
were counted per mm sectional area and per mm length of
epithelium. LC were reduced in number by all markers in HPV
lesions and in CIN. S100 positive cells were almost completely
depleted in abnormal epithelium and the authors postulate that the
S100 protein may mark a histogenetically distinct subpopulation of
LC, with a different functional role. The significance of this
finding is, however, somewhat uncertain as S100 is also present on
melanocytes (Halliday et al, 1986) and on some T suppressor cells
(Takahashi et al, 1985).
Hawthorn et al (1988) studied the relationship between the
number of LC and the presence of HPV types 16 and 18 in CIN. They
found that the number of LC present was inversely related to the
number of copies of HPV 16 DNA per cell present, and that the
presence of HPV 18 DNA, even at low copy numbers, reduced the LC
numbers significantly. Thus these HPV types may affect the local
afferent immune response and help to explain their suggested
oncogenic potential.
ii) T lymphocytes in HPV induced lesions and in CIN
Some of the above studies quantified T cell subsets, in
addition to LCs, within the cervical transformation zone (TZ).
Morris et al (1983) found that CD8 positive (suppressor/
cytotoxic) T cells outnumbered CD4 positive (helper/inducer) T
cells in normal cervical epithelium. This corresponds to the
pattern described by other workers in the skin, gut and male
genital tract (see above). In HPV associated cervical lesions
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positive cells still exceeding CD4 positive cells in number.
Other workers (Edwards and Morris, 1985; Tagami et al, 1983)
have confirmed these findings, i.e. CD8 positive cells outnumber
CD4 positive cells in normal and abnormal cervix.
In contrast, Syrjanen et al (1984) found that although CD8
positive cells exceeded CD4 positive cells in HPV lesions (with no
CIN), the ratio was reversed in CIN. Tay et al (1987b) reported
the reverse of this situation; i.e. CD4 positive cells were more
numerous in normal cervical epithelium but CD8 positive cells were
in the majority in abnormal (koilocytic and neoplastic) epithelium.
Clearly the picture regarding T cell subsets within the
cervical TZ requires clarification.
DNA analysis of invasive and preinvasive lesions
Introduction
The DNA content of tumours can be analysed using one of three
techniques; these are chromosome analysis, static cytometry and
flow cytometry. The principles involved in chromosomal analysis
and static cytometry will be outlined briefly here and flow
cytometry will be described in more detail.
Chromosomal analysis
The application of this technique to the study of solid
tumours has been reviewed recently (Sandberg and Turc-Carel, 1987).
The technique is ideal for the study of leukaemias but solid
tumours require mechanical or enzymatic disaggregation and in many
cases this means that interpretable chromosome spreads cannot be
obtained. Modern tissue culture techniques are helping to solve
this problem.
Once a single cell suspension has been obtained it is exposed
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to a mitotic inhibitor and prepared on glass slides. The
interaction of alkylating fluorochrome and histochemical stains
produces multiple characteristic bands which can be identified on
metaphase chromosomes (Verma and Dosik, 1982).
The normal human somatic cell with 46 chromsomes is referred
to as diploid (Tijo and Levan, 1956). Cells with three or more
complete sets of the haploid component (i.e. multiples of 23
chromosomes in man) are known as polyploid and cells with a
chromosome content differing from the diploid but not by a complete
haploid set are known as aneuploid. A cell with a balanced gain or
loss of chromosomes, or with structural rearrangements, that still
has 46 chromosomes, is pseudo-diploid.
Static cytometry
Cellular DNA can be measured by one of two procedures. The
Feulgen-Schiff technique entails removal of the purines from DNA by
acid hydrolysis and the subsequent reaction of the exposed aldehyde
groups of deoxyribose sugars with aldehyde specific Schiff
reagents. The second method relies on the use of fluorescent dyes
which bind directly to DNA in a stoichiometric fashion - that is
the degree of staining is directly proportional to the amount of
DNA present .
Stained single cells are then visualised by a microscope based
system and the amount of DNA bound dye measured directly or by
absorption or fluorimetric means (Caspersson, 1979). In contrast
to chromosome analysis, this technique can be used to examine
interphase cells independent of the proliferative activity of the
tissue. The detection of a chromosomal abnormality by static and
flow cytometry is a function of its relative frequency within the
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population studied, the amount of aberrant chromosomal material
involved, and the resolution of the technique used. Static
cytometry is applicable to the analysis of formalin fixed tissue or
fixed smear preparations from tumours, where the DNA content of
morphologically identified tumour cells can be measured. Owing to
the relatively slow data acquisition rates of the procedure,
however, measurement of DNA content is usually restricted to
several hundred cells in any one sample.
Flow cytometry
This recently developed technique permits the rapid
examination of many thousands of cells and as a result has replaced
static cytometry in many centres. The major disadvantage of the
technique, which does not apply to static cytometry, is that
specimens to be analysed must be reduced to a single cell
suspension. This means that information concerning structural
relationships in solid tissues is lost.
Tissue can be disaggregated and stained when fresh or after
frozen storage (Stone et al, 1985) or retrieved from paraffin
embedded blocks (Hedley et al, 1985). Alternatively cytological
samples can be analysed in what appears to be one of the most
exciting applications of the technique from a diagnostic point of
view. Cervical brushings or smears (Elias-Jones et al, 1986;
Linden et al, 1979), bladder washings (Melamed and Klein, 1984)
pleural effusions (Czerniak et al, 1985) or semen (Evenson et al,
1982) can be studied.
Within the flow cytometer the single cell suspension
encounters a laser or other light beam and information is obtained
regarding the size and granularity of the cells [see figure 9]. A
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Figure 9 Schematic representation of flow cytometry. For
explanation see text.
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DNA specific fluorescent dye may be used to obtain a quantitative
assessment of DNA content and antibodies to surface and nuclear
antigens may be labelled with fluorescent stains to obtain
information about the expression of these antigens. Assessment of
enzyme activity (Quirke and Dyson, 1986), steroid receptors (Kute
et al, 1983), and intracellular pH (Visser et al, 1979) and calcium
(Quirke and Dyson, 1986) is also possible.
Cell populations of particular interest may be sorted from
accompanying cells by applying an electrical charge to those of
interest. The cell stream then passes between two high voltage
plates and the cells are deflected according to their charge. In
this way rare populations of cells such as fetal cells (Hezenberg
et al, 1979) and trophoblast (Covone et al, 1984) in the maternal
circulation have been concentrated. The sorting of human
chromosomes (Young et al, 1981) has produced genomic libraries of
cloned DNA (Davies et al, 1981) and the isolation of substantial
quantities of pure single chromosomes for molecular biological
studies (Collard et al, 1985).
Flow cytometry has been used to study two aspects of the DNA
content of tumours. These are: [a] DNA aneuploidy and [b] cell
cycle kinetics,
a) DNA aneuploidy
A recent working party report on nomenclature in flow cytometry
(Hiddemann et al., 1984) has recommended that the term aneuploidy
be reserved for chromosomal studies and should be modified to DNA
aneuploidy when describing flow cytometric data. DNA aneuploidy
is defined as the presence of an "abnormal DNA stem line" and
Hiddemann et al recommended that it should only be reported when at
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least two separate G^/Gj peaks are demonstrated.
Aneuploidy is a well recognised feature of human tumours and
until recently has been regarded as being confined to malignant or
premalignant conditions. The recent identification of chromosomal
abnormalities in benign tumours such as lipomas (Heim et al, 1986)
and meningiomas (Zang, 1982) and of DNA aneuploidy in meningiomas
(Danova et al, 1987), benign thyroid tumours (Johannessen et al,
1982), benign monoclonal gammopathies (Montecucco et al, 1984) and
in cervical warty atypia (Evans and Monaghan, 1985) make it
necessary to re-examine this assumption. Nonetheless, a large
body of work suggests that the development of aneuploidy is a
significant event in the process of carcinogenesis and has serious
prognostic implications (for review see Friedlander et al, 1984a).
DNA aneuploidy has been shown to be inversely related to
differentiation in bladder (Chin et al, 1985) and breast tumours
(McGuire and Dressier, 1985) and in non-Hodgkin's lymphoma (Diamond
et al, 1982). It can be used to predict invasive potential in
preinvasive bladder carcinoma (Gustafson et al, 1982) and in
borderline ovarian lesions (Friedlander et al, 1984b). Patients
with DNA aneuploid rectal adenocarcinomas have a poorer chance of
surviving for five years than those with tetraploid tumours (with
twice the normal diploid DNA content) (Quirke and Dyson, 1986).
DNA aneuploidy has been shown to increase with increasing
severity of disease in CIN (Jakobsen et al, 1983; Reid et al,
1984). This is in accordance with cytogenetic investigations
which show that only 29% of cases of cervical CIS have a chromosome
number in the diploid range (Spriggs et al. , 1971). Nasiell et al
(1979) were, however, unable to demonstrate a significant
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correlation between aneuploidy and progression in CIN in a study
employing static cytometry to examine cervical smears. Evans and
Monaghan (1985) also used static cytometry to investigate cervical
warty atypia and found that aneuploid cases did not regress, while
approximately half the diploid and polyploid cases did regress over
one year.
A significant correlation has been demonstrated between "DNA
index" and the incidence of pelvic node metastases in squamous
cervical carcinoma, with "high ploidy" (DNA index > 1.5 if diploid
= 1) tumours having a higher likelihood of metastasising (Jakobsen,
1984a). A second flow cytometric study by Jakobsen (1984b) of
patients with cervical carcinoma also showed that patients with low
ploidy (DNA index < 1.5) had a significantly better prognosis that
those with high ploidy. The distribution of ploidy was not
correlated with stage, and there was a significantly higher
recurrence frequency in patients with high ploidy tumours in all
stages investigated. This is interesting as it has been suggested
that DNA tetraploid tumours behave less aggressively than their DNA
aneuploid counterparts in prostatic (Ronstrom et al, 1981) and
bladder (Tribukait et al, 1982) carcinomas, tending to be of lower
histological grade and stage.
These data, together with experimental findings (Isaacs et al,
1982) lend support to the suggestion that karyotypic progression in
tumours occurs first by doubling the chromosome number to DNA
tetraploidy with subsequent loss or gain of chromosomes producing
DNA aneuploidy (Nowell, 1976). At this stage the expression of
recessive oncogenes may occur (Atkin, 1985) which might explain
enhanced biological aggressiveness.
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b) Cell cycle analysis
There are problems inherent in the analysis of the cell cycle
by flow cytometry. These stem from the fact that DNA content is
measured at a single point in time, rather than over a period of
time. Samples which contain a large percentage of cells in the S
and G2+M phases of the cell cycle (see figure 10) are assumed to
contain a large percentage of dividing cells. It is, however,
theoretically possible that these cells have longer S and G2+M
phases, and a shorter Gq/G^ phase than other cells, and are
dividing at the same rate. This possible interpretation must
always be remembered but S and G2+M phase percentages are generally
assumed to reflect the rate of cell division.
Much less work has been performed in this area with respect to
human tumours than in the area of DNA aneuploidy. It is reported
that low S phase breast tumours are more likely to be oestrogen
receptor positive (and thus to have a better prognosis) than are
high S phase tumours (McGuire et al, 1985). In non-Hodgkin's
lymphoma a high percentage of cycling cells is found significantly
more often in high grade tumours (Braylan et al, 1980) and a high S
phase fraction in low grade lymphomas may predict progression to a
higher grade tumour (MacCartney et al, 1986).
Oncogenes and human tumours
Oncogenes were first isolated as part of the genomes of rare
RNA tumour viruses known as acute transforming retroviruses, which
efficiently transform cells in culture and cause tumours in
animals. Over two dozen viral oncogenes have now been identified in
the genomes of DNA and RNA viruses, encoding a wide diversity of









known of how the proteins act and the nature of the tumours they
induce.
Three biochemical strategies have been identified by which the
products might act in inducing carcinogenesis. These are
phosphorylation, initiation of DNA synthesis and regulation of
transcription.
a) Phosphorylation
Both proteins and phospholipids are potential substrates for
phosphorylation. The transforming protein may be a factor that
elicits phosphorylation, such as a ligand that binds to a receptor
on the cell surface; or it may be the catalytic kinase itself.
Alternatively it may act on phosphorylation at a distance, by
regulating adenylate cyclase and thus the activity of protein
kinases controlled by cyclic AMP. The v-src and v-abl oncogene
products are protein-tyrosine kinases and thus are examples of this
class of protein (Bishop and Varmus, 1982).
b) Inititation of DNA synthesis
Unrestrained synthesis of DNA is an inevitable component of
the neoplastic phenotype. Some transforming proteins allegedly
elicit this property by acting directly to initiate DNA synthesis
(e.g. the simian virus 40 large T antigen (Martin, 1981)).
c) Regulation of transcription
Several of the transforming proteins may influence
transcription from cellular genes, either by stimulation or by
inhibition. They may do so by interacting with other proteins,
with promoters for transcription, or with enhancers (Kingston et_
al, 1985).
The adenovirus EIA products are believed to inhibit
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transcription from MHC class I genes (Schrier et al, 1983) and the
v-myc product is also believed to regulate transcription (Bishop,
1985; Studzinski et al, 1986).
Normal vertebrate cells contain similar but non-identical
copies of viral oncogenes. These cellular genes have been termed
cellular oncogenes (c-oncs) or proto-oncogenes. It has become
clear that viral oncogenes arose as a consequence of genetic
recombination between slow retroviruses and cellular oncogenes
(Bishop, 1983). Unlike viral oncogenes, however, cellular oncogenes
do not normally transform cells. Their expression in normal cells
appears to be under tight control for they are expressed only in
small quantity and only at appropriate stages of differentiation
and cell division. A role for oncogenes in spontaneous
transformation has been strongly suggested by the finding that
tumour cells often possess proto-oncogenes that are genetically
altered, compared to a normal cellular counterpart from the same
individual.
The myc oncogene
The myc oncogene encodes a product which localises in the
nucleus (Persson and Leder, 1984) and which appears to have some
structural similarity with the EIA-transforming protein of
adenoviruses (Kelly and Siebenlist, 1986). It is thought to act
as a transcriptional regulator (Bishop, 1985). C-myc is
ubiquitously expressed in almost all differentiated cell types,
where its expression is differentially regulated in resting and
activated cells. Increased c-myc expression is closely associated
with the entry of a cell from Gq into the cell cycle, while almost
complete shut off of c-myc expression accompanies the inhibition of
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proliferation associated with differentiation (Kelly and
Siebenlist, 1986).
Structural alterations in the c-myc gene and abnormal
expression of the c-myc product have been observed in numerous
tumours, particularly B and T cell malignancies.
Murine plasmacytomas and human Burkitt's lymphoma are
characterised by consistent reciprocal translocations involving the
c-myc locus and one of the three immunoglobulin loci (Bernheim et_
al, 1981). It is thought that these translocations result in
deregulation of c-myc transcription. All, or almost all of the
c-myc RNA present originates from the translocated allele with
little or no transcription originating from the germline allele
(Leder et al, 1983). C-myc may be negatively regulated by a
mechanism that can repress the normal gene but not the translocated
allele.
Gene amplification of c-myc has been described in relation to
a variety of malignancies (Kelly and Siebenlist, 1986). A causal
role for c-myc amplification in contributing to the degree of
malignancy has been suggested by the observation that highly
malignant small cell lung carcinoma cells show c-myc gene
amplification, while less malignant small cell lung carcinoma cells
do not necessarily do so (Little et al, 1983). In the cervix it
has been shown that stage 3 and 4 carcinomas display c-myc DNA
amplification while stage 1 carcinomas do not (Riou et al, 1984;
Ocadiz et al, 1987) and that stage 1 and 2 carcinomas in which
c-myc overexpression (relative to normal) is detected are more
likely to relapse after treatment than carcinomas in which such
over-expression is not detected (Riou et al, 1987). There is little
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published work on c-myc expression in CIN but it is interesting
that one group report a higher level of c-myc expression by
epithelial cells from normal cervix than by cells from CIN or
cervical carcinoma (Hendy-Ibbs et al., 1987). The same group
obtained similar results in biopsies taken from testicular
teratomas where c-myc was expressed at a higher level in well
differentiated tumours than in undifferentiated tumours (Watson et
al, 1986).
Although it is accepted that the c-myc product acts as a
transcriptional regulator, its role in tumorigenesis is not yet
understood and it is not therefore possible to ascribe functional
significance to these findings at present.
PURPOSES OF THE PRESENT STUDY
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PURPOSES OF THE PRESENT STUDY
Epidemiological data (Chapter 3)
This section was designed to obtain and collate information
concerning the reproductive, contraceptive, sexual and smoking
histories of patients with cervical intraepithelial neoplasia (CIN)
and invasive carcinoma and of normal controls who attended the
Lothian Area Colposcopy Clinic and the Royal Infirmary, Edinburgh.
This information made it possible to compare women with
cervical neoplasia in South-East Scotland with normal controls in
this area and with patients and controls elsewhere and to identify
any epidemiological features distinguishing patients with cervical
neoplasia from normal controls.
The local immune response to the human papilloma virus (HPV) and CIN
in the uterine cervix (Chapter 4)
In this section the local immune response was characterized by
enumerating Langerhans cells (LC) and T lymphocytes within normal
and abnormal cervical transformation zone epithelium. LC and T
cells were counted, any alteration in distribution and morphology
noted, and expression of MHC Class II antigens HLA-DP, -DQ, and -DR
assayed. An attempt was made to relate these features to the
presence or absence of HPV infection (in the form of koilocytosis),
to the grade of CIN, to such factors as smoking and oral
contraceptive use, and to clinical outcome in order to elucidate the
role played by local immune interactions in the development of
cervical neoplasia.
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Flow cytometric analysis of DNA content, c-myc protein expression
and papillomavirus antigen expression In cervical biopsy and brush
specimens (Chapter 5)
The DNA content of biopsies and brush specimens from normal
and abnormal cervical epithelium was examined to look for evidence
of aneuploidy. Particular attention was paid to the DNA content of
koilocytic cervical epithelium, as it was felt that the detection
of aneuploidy here would provide evidence to support the theory
that HPV infection can lead to neoplastic change. The rate of
cell division in koilocytic and neoplastic epithelium was also
examined, in order to gain further understanding of the effects of
HPV infection on cervical epithelium.
The c-myc oncogene is known to be abnormally expressed in
numerous human tumours (see Chapter 1, page 63) and its expression in
HPV infected and neoplastic epithelium was compared with expression
in normal cervical epithelium. C-myc expression is known to be
closely associated with stage of the cell cycle and a double
staining technique was employed to examine the relationship between
c-myc expression and cell cycle kinetics.
A similar technique was employed to relate expression of
papillomaviral antigens to cell division.
Cervical intraepithelial neoplasia and cervical HPV infection in
patients with lymphomas (Chapter 6).
This chapter describes a clinical survey designed to
investigate the effect of immunosuppression on the prevalence of
cervical HPV infection and CIN. Female patients with Hodgkin's and
non-Hodgkin's lymphomas underwent cytological and colposcopic
screening in order to compare the prevalence of cervical
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abnormalities in this group with the prevalence of abnormalities in
a normal control population. The data obtained from this survey
provides further understanding of the role of the immune system in







Theee groups of control patients were studied. One group of
12 patients (control group "A") were women with normal cervical
cytology who were referred to the Lothian Area Colposcopy Clinic
due to concern about the appearance of the cervix, or because of
post coital bleeding. None of these patients had ever had a
suspicious cervical smear, but six had previously had inflammatory
smears. One of these women was found to have CIN II and three had
evidence of cervical HPV infection in the form of koilocytosis
(n=2) or presence of HPV antigen (n=l) [see page 129 ]• These four
women were included as controls for comparison with lymphoma
patients (see below) but cervical biopsies and brushings from them
were not included in the "normal control" group for other
experiments. No colposcopic or histological evidence of
koilocytosis or CIN was found in any of the remaining patients. In
three of this group, cervical biopsies and/or brushings were
examined by flow cytometry for the presence of HPV antigen, and
found to be antigen negative. HPV antigen was not looked for in
biopsies or brushings from the other five controls in this group,
and the possibility of HPV infection was therefore not excluded.
A full reproductive, contraceptive, sexual, smoking and
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cervical smear history was taken from all women in this group, and,
after colposcopy and histology had revealed no abnormality, they
were referred back to source for routine cytological screening.
Four patients were given cold coagulation treatment to the cervical
transformation zone to prevent further intermenstrual bleeding,
before being referred back to source.
The second group of control patients (control group "B") were
ten women undergoing minor gynaecological procedures (laparoscopic
sterilisation, dilatation and curettage, etc) and three women who
underwent total abdominal hysterectomy. Informed consent for
cervical biopsy was obtained and colposcopic examination was not
performed. All 13 women had had normal cervical cytology within
the preceding three years and random biopsies taken from their
cervical transformation zones were reported as containing no
abnormality. Cervical biopsies from two of these women contained
HPV antigen [see page 129 ] and they were therefore transferred from
the "normal" group to the "HPV infection" group. Cervical
biopsies from two further women in group "B" were found to be
negative for HPV antigen, while biopsies from the nine remaining
controls in this group were not analysed for the presence of HPV
antigen. A sexual history was not taken from these patients, and
they were not used as normal controls for the purpose of comparison
with the lymphoma patients (see below). The third group of
control patients (control group 'C') were 69 patients undergoing
minor gynaecological procedures such as dilatation and curettage or
laparoscopic sterilisation. They had never had a suspicious
cervical smear and had had a normal smear within the preceding
three years. A full reproductive, sexual, smoking, gynaecological
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and cervical smear history was taken from all group 'C' controls
and informed consent was obtained for colposcopy and cervical punch
biopsy from each control. Colposcopic examination was performed on
all women in this group. A proportion of these examinations were
performed by the author, with the remainder being performed by
another trained colposcopist, Dr Mohammed Alloub. Group 'C'
controls were compared with lymphoma patients, but cervical
biopsies from them were not processed for immunoperoxidase staining
or for flow cytometry.
Patients with cervical HPV infection or CIN
Twenty three patients with evidence of cervical HPV infection
in the form of koilocytosis, and 140 patients with CIN were
studied. They had been referred to the Lothian Area Colposcopy
Clinic on account of one or more suspicious cervical smears, or
because of concern about the appearance of the cervix. A full
reproductive, contraceptive, smoking and sexual history was taken,
and full colposcopic examination of the lower genital tract carried
out. Colposcopically directed punch biopsies were taken from all
abnormal areas visualised, and in all but 13 of the patients
included in this study, one biopsy specimen was divided; half being
fixed for routine histopathology and half being snap frozen as
described below. Three patients with koilocytosis only and 10
with CIN had biopsies taken for routine histopathology, but the
biopsy was not divided and only cervical brushings were taken for
the purpose of this study.
All patients with CIN II or III received treatment either on
the same day, or 2-9 weeks later. The treatment given was either
local ablative therapy to the cervical TZ in the form of CO2 laser
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or cold coagulation treatment, or cone biopsy. Patients with CIN
I or koilocytosis alone received either cold coagulation treatment
or entered a clinical trial in which they were randomised to
receive no treatment, to use condoms, or to receive CC^ laser
treatment. All patients had a cervical smear taken 6 months after
treatment, and repeat colposcopic examination and cervical smear 12
months after treatment.
Patients with invasive cervical carcinoma
Eleven patients undergoing extended abdominal hysterectomy for
invasive squamous cervical carcinoma were studied. A
reproductive, contraceptive and smoking history was taken from each
patient, but sexual histories were not obtained. Biopsy specimens
were taken from the tumour (n=7), from adjacent cervical epithelium
(n=7) and from external and internal iliac lymph nodes (n=ll)
within 20 minutes of the uterus and nodes being removed from the
patient. Each biopsy specimen was divided; half was fixed for
routine histopathology and half was snap frozen (see below)
Lymphoma patients
A group of 45 female patients attending the Department of
Haematology, Royal Infirmary, Edinburgh under the care of Dr A.C.
Parker or Dr C.A. Ludlam were invited to participate in this study.
They were diagnosed as suffering from Hodgkin's or non-Hodgkin's
lymphomas, all had been sexually active in the past or at present,
and were between the ages of 16 and 60. Twenty seven agreed to
take part in the study. Ten patients did not wish to participate
and eight were excluded for other reasons; five having undergone
total abdominal hysterectomy, one being pregnant, and two living
out of Edinburgh.
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A full history (as for CIN patients) was taken from all
patients and they underwent full colposcopic examination. A
cervical smear was taken from all patients while cervical punch




The cervix was visualised using a Cusco's bivalve speculum and
mucus removed from it using a dry swab. The colposcope was then
focussed on the cervix using a magnification of xlO to allow a
large area around the external os to be seen in one field.
Magnification was increased to xl6 to permit a more detailed view
of a smaller field and optimal contrast was obtained by insertion
of a green filter.
The vascular pattern of cervical epithelium was examined and
abnormalities such as punctation and mosaicism sought. These
abnormalities may signify neoplastic change. "Atypical" vessels,
i.e. terminal vessels strikingly irregular in size, shape, course
and mutual arrangement are found almost exclusively in
microinvasive and invasive disease. The surface contours of the
cervix and any lesions seen were examined.
Three per cent acetic acid was applied to the cervix at this
stage. This coagulates cytoplasmic and nuclear proteins of the
epithelium making them opaque and white. In CIN III, which is
characterised by cell "crowding", there are more cells and thus
more protein per unit area of epithelium than in CIN I or in normal
squamous epithelium. CIN III therefore appears whiter following
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the application of acetic acid than CIN I or normal epithelium.
Vascular changes such as punctation and mosaicism become more
apparent when acetic acid has been applied, and the border between
abnormal and normal epithelium can be visualised. CIN II and CIN
III are characterised by sharp boundaries while CIN I and immature
squamous metaplasia possess less distinct borders. Flat
koilocytic lesions and condylomata acuminatum may take on the
appearance of acetowhite islands surrounded by normal squamous
epithelium and can thus be distinguished from areas of CIN which
are found within the TZ and therefore very rarely appear to be
completely surrounded by normal squamous epithelium.
Aqueous iodine solution B.P. (Ransom and Son pic) was then
applied. Glycogen appears dark brown after the application of
iodine; thus native squamous epithelium and mature metaplastic
squamous epithelium is stained brown. Columnar epithelium, areas
of immature metaplasia, some inflammatory lesions and CIN lesions
contain much smaller amounts of glycogen and are stained a light
yellow. After the menopause squamous epithelium becomes thinner,
loses much of its glycogen content and thus also takes on a light
yellow appearance after the application of iodine. Iodine
application destroys the finer detail seen after the application of
acetic acid but is useful in demarcating the extent of any
abnormality and particularly in determining whether or not lesions




An Ayre's spatula was used to obtain samples for routine
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cervical cytology. The "hook" end of the spatula was placed in
the cervical os and rotated through 360° (see figure 3). The
exfoliated cells obtained were then spread on a glass slide and
fixed immediately in methylated spirit (740P). Smears were then
processed for routine cytological screening and graded according to
the standard Lothian Area classification as follows:
0 = unsatisfactory
1 = normal
1+ = inflammatory changes bordering on mild dyskaryosis
2 = dyskaryosis consistent with CIN I or CIN II
3 = malignant cells seen, consistent with CIN III or
invasive carcinoma.
Koilocytes (Meisels and Fortin, 1976) were reported if present.
The cervical smears taken from patients with lymphomas did not
go through the routine screening process but were read by Dr M.
Colquoun, cytopathologist. All previous smears from these patients
that could be traced were reviewed by Dr Colquhoun.
b) Cervical brush specimens
A Cytobrush (Medscand) (Glenthoj et al, 1986) was used to
obtain these specimens with the bristle end of the brush bent over
at an angle of about 50°. The distal end was inserted just inside
the external os and the brush rotated through 360° in order to
obtain exfoliated cells from the whole of the TZ. The plastic
holder was then cut in half and the brush placed in a sample tube
containing 5 ml methanol or 5 ml 1% formol saline in phosphate
buffered saline (PBS) [see figure 11]. The sample was stored at
room temperature until processed further. Satisfactory results
were obtained from samples stored for up to four months in this




Biopsy specimens of cervical epithelium may be obtained by
punch biopsy, wedge biopsy, endocervical curettage or cone biopsy.
Only punch biopsy was used in this study; the other techniques
will not therefore be discussed.
(
Punch biopsies were taken from the TZ of patients and controls
using Schumacher biopsy forceps. Those from patients and from
group A and group C controls came from colopscopically abnormal
areas. Cervical biopsies were not taken from patients with
lymphomas if the cervix appeared entirely normal. The biopsy
specimen was immediately divided; half was placed in fixative for
histopathological assessment as part of the routine diagnostic
process and half was snap frozen in O.C.T. compound (Mackay and
Lynn) on dry ice, and stored at -70°C until processed further.
Histopathology
A cryostat section 8 ^im in thickness was cut from the centre
of each biopsy specimen and placed on a slide. It was air dried,
fixed in acetone at 4°C for 10 minutes and stained with eosin (5
seconds) and Mayer's haemalum (20 seconds) for routine
histopathological assessment. CIN was graded according to
recognised criteria (Buckley et al, 1982) and features suggestive
of HPV infection (koilocytosis, multinucleation, individual cell
keratinisation) were reported if present.
Major histocompatibility (MHC) class II antigen, Langerhans cell
(LC) and T cell staining
Serial cryostat sections (8 ^.im thickness) were prepared,
mounted on poly L-lysine coated slides, fixed in acetone at 4°C for
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10 mins, and air dried. Sections were then stained using an
indirect immunoperoxidase technique adapted from the method of Carr
et al (1986). Briefly, sections were incubated in 20% normal
rabbit serum (NRS) in 0.001M Tris-buffered saline (TBS) pH 7.6 for
20 mins. Excess serum was shaken off and sections then incubated
for 45 minutes with mab (Table 2) at room temperature. DAKO T6 is
ascitic fluid (Thomas et al, 1982) and all other mabs are culture
supernatants (Watson et al, 1983; Pawelec et al, 1982; Lampson &
Levy, 1980; Guy et al, 1982). The optimal dilution of antibody
made in 2% NRS was determined by titration. Negative controls were
prepared by substituting 2% NRS for mab. Sections were then
washed twice in 2% NRS and incubated with a rabbit antiserum to
mouse immunoglobulins conjugated with horseradish peroxidase
(DAKOPATTS) diluted 1 in 80 in 2% NRS for 15 mins. The enzyme
reaction was developed using diaminobenzidine (Sigma, Poole,
Dorset) with 0.068% imidazole (BDH) and 0.02% hydrogen peroxide in
Tris buffer (pH 7.4). All incubations were carried out in a moist
chamber.
Quantification of LC and T cells
The squamous epithelium included in each section was
photographed. If the whole area of epithelium was too large to be
included in one frame a series of overlapping photographs were
taken. These were printed and assembled as a composite
representation. The outline of the squamous epithelium
photographed was then traced on to tracing paper and the outline
cut out. The tracing paper representing each sample was weighed
and the surface area of the squamous epithelium calculated from
this measurement. Cells possessing at least two dendrites
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Table 2
Origin and specificity of monoclonal antibodies.
Monoclonal Working
antibody dilution Origin Specificity
DAK0-T6 1:20 DAKOPATTS
(Thomas et al 1982)
Langerhans cells, common
thymocytes
DA6.231 1:10 K. Guy
(Guy et al 1982)
HLA-DP, HLA-DQ, HLA-DR
B7/21 neat I. Trowbridge
(Watson et al 1983)
HLA-DP
TU22 neat A. Ziegler HLA-DQ







(Lampson & Levy 1980)
UNIPATH
HLA-DR
CD3 (expressed by all T
lymphocytes)
DAK0-T4 1:10 DAKOPATTS CD4 (expressed by most
helper/inducer T
lymphocytes)




attached to a cell body and staining positively with DAKO T6 were
classified as LC. All T6 positive LC or CD3 positive T cells
within the epithelium were then counted and counts expressed as
2
cells per mm as this has been found to be most reliable method of
enumerating LC (De Jong et al, 1986).
Statistical analysis
The significance of the difference between each group and the
control group was calculated using the Mann-Whitney U test.
Preparation of nuclei for flow cytometry
A single 8 pm cryostat section was taken from the centre of
each cervical, prostatic and lymph node biopsy specimen to be
processed for flow cytometry, and prepared for routine
histopathological assessment as described above. The remainder of
the specimen was thawed, minced and incubated according to a
modification of the method of Hedley et al. (1983). It was
incubated in 3 ml 0.5% pepsin solution (Sigma) in 0.01M phosphate
buffered saline (PBS), with the pH adjusted to 1.5 with
hydrochloric acid, at 37°C for 45-60 minutes. The supernatant was
drawn off and centrifuged (all concentrations were at 700 x g for
10 minutes), and the resultant pellet washed in PBS and respun.
Any clumps of nuclei were dispersed by syringing through a fine
gauge needle (26G).
Cervical brush specimens were prepared for flow cytometry by
first centrifuging the entire specimen (including the brush) at 700
x g for 10 minutes and removing the methanol or formol saline.
After one wash in PBS and a further centrifugation the sample was
resuspended in 5 ml pepsin solution (as described above). After
incubation for 45 minutes at 37°C the brush was agitated in the
80.
solution and then discarded. The nuclei released by the procedure
were then centrifuged and the supernatant discarded. The nuclei
were washed in PBS and respun.
Staining of nuclei for flow cytometry
1. Nuclear antigens
Nuclei were fixed in 1% formol saline in PBS containing 2%
normal sheep serum (NSS) for 10 minutes at room temperature. They
were centrifuged and resuspended in 20% NSS in PBS at a
concentration of 10^ nuclei/ml for 20 minutes, and nuclear antigens
stained by a modification of the method of Elias-Jones et al
(1986). Nuclei were centrifuged and resuspended in primary
antibody (200 jil per 10^ nuclei) overnight at 4°C (see table 3).
Primary and secondary antibodies were diluted in 2% NSS in PBS.
Nuclei were then washed twice in 2% NSS in PBS and fluorescein
isothiocyanate (FITC) conjugated secondary antibody (see table 3)
added for 45 minutes at 4°C. Nuclei were then washed twice in 2%
NSS in PBS and stored in 1% formol saline in the dark. Nuclei
could be stored under these conditions for up to two weeks with no
loss of staining. Controls were prepared by substituting 2% NSS for
primary antibody. Chippings obtained from six patients at trans¬
urethral resection of prostate for benign prostatic hypertrophy
were snap frozen and processed as described for the cervical
biopsies. They were then stained with antibody to papillomavirus
antigens and used as controls for these experiments.
2. Nuclear DNA
The nuclear suspension was stained with a modified method of
Deitch et al (1982) (see figure 12).









































































mixture treated with RN ase
and stained with propidium iodide
Figure 12. Method of preparing nuclei for DNA staining
(see text for explanation).
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jig propidium iodide (Sigma) per ml in 0.01M Tris (pH 7.0) with 5 mM
magnesium chloride, 0.1% Triton X-100 and 15 pg ribonuclease
(Sigma) per ml and incubated at 4°C for 15 minutes to 2 weeks.
DNA staining was carried out on unstained nuclei (immediately after
pepsin digestion) or on nuclei stained with antibodies to nuclear
antigens and FITC labelled conjugates.
Chicken red blood cells (CRBC) were run with each sample as an
internal control, the DNA content of such cells being 35% of that
of a human diploid cell (Vindelov et al, 1983) [figure 13]. They
were stained with the propidium iodide solution as described above.
Human peripheral blood lymphocytes were stained and run with CRBC
as a further DNA control at the start of each run.
Flow cytometer
The flow cytometer employed was an EPICS 'C' (Coulter) [figure
14]. The stained nuclear suspension was injected into the flow
cell [see figure 9] where it was hydrodynamically focussed into
"indian file" for passage through the interrogation point. The
nuclei interacted at this point with the laser beam. The laser in
the EPICS 'C' flow cytometer is an argon ion laser which emits
light at 488 nm and was set at an output of 100-200 mW. Light is
scattered in all directions by nuclei crossing the laser beam.
Light scatter in the forward direction is related to the size of
the nucleus and that at 90° to the degree of refraction of its
internal structure. Excitation of propidium iodide and FITC
occurred at the interrogation point with emission of light of a
longer wavelength (see figure 9). This was also collected at 90°;
selected wavelengths were directed by dichroic mirrors to
photomultiplier detectors and unwanted fluorescence and scattered
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Figure 13. Representative DNA histogram showing cervical
nuclei and chicken red blood cell nuclei (CRBC)
(LRFL = log red fluorescence, AL = CRBC, AU =
cervical nuclei in Gq/G^ phases, BL = cervical
nuclei in + M phases ).
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Figure 14. EPICS 'C' flow cytometer
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laser light were blocked by optical filters. Electrical signals
were generated for each particle and converted to digital signals
for processing by computer software in order to generate one
parameter or two parameter correlated histograms.
Flow cytometry - nuclear antigen staining
A total of 40,000 nuclei were analysed from each sample at a
flow rate of 400-500 nuclei/second. The nuclear fraction was
selected by gateing on a one-parameter histogram measuring forward
angle light scatter (FLS) or log FLS (LFLS) and the percentage of
nuclei showing fluorescence greater than the background level was
recorded. Fluorescent signals were simultaneously acquired from a
two-parameter histogram measuring FLS against 90° light scatter,
using a bit map around the nuclear population. The results from
both histograms differed by less than 2%, and all results presented
are those acquired by gateing on LFLS signals.
Flow cytometry - nuclear DNA staining
Nuclei were run at a rate of 150/second until 20,000 stained
nuclei had been counted. The data obtained were subjected to
parametric analysis with the EPICS PARA 1 program, which determined
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The subjects of this thesis were compared to patients with CIN
studied elsewhere, and any differences in their sexual,
contraceptive or smoking habits identified. Patients with
papillomavirus infected or neoplastic cervical epithelium were
compared to normal controls, in order to discover whether the risk
factors described by other authors (see Chapter 1, "The
epidemiology of squamous carcinoma of the uterine cervix") also
apply to women in South-East Scotland.
Results
The information obtained from the three groups of normal
controls and from patients with HPV infection, CIN and
invasive carcinoma is shown in table 4. It can be seen that the
age range of patients in all groups was very similar, except for
group C controls who were slightly older. The percentage of parous
patients and the percentage of women using the oral contraceptive
and barrier methods of contraception was similar in all groups
while the percentage of patients with CIN III and with invasive
disease who smoked was significantly higher than the percentage of
2
women in the control groups who smoked (% =10.87, P < 0.01 if
patients with CIN III and invasive disease are compared with Group
2
C controls alone; % = 8.49, P < 0.01 if these patients are
2
compared with Group A + C controls and = 6.48, p < 0.02 if they
are compared with Group A,B and C controls). The difference
2
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0.1) if CIN I and II patients are included with CIN III and
invasive disease for comparison with Group A,B and C controls. A
sexual history was not obtained from group "B" normal controls or
from patients with invasive carcinoma but in all other groups age
at coitarche and median number of sexual partners was very similar,
and did not vary significantly between groups.
Tables 5 and 6 contain information concerning number of sexual
partners and age at coitarche of the patients and controls included
in the present study, and of patients with CIN and controls studied
as part of four recent epidemiological surveys conducted elsewhere
in Europe. La Vecchia et al (1984) and Zaninetti et al (1986)
studied women in Milan, Italy, Vonka et al (1984) women in Prague,
Czechoslovakia and Hellberg et al (1986) women in Falu, Sweden.
The women studied by Zaninetti et al were all younger than 20.
It can be seen from table 5 that the number of sexual partners
reported varied greatly from country to country, and that there
were larger differences between controls in different studies than
between controls and cases within some studies. Thus 9% of the
controls, and 23% of patients with CIN in the group studied by La
Vecchia et al reported three or more sexual partners while the
corresponding figures from Hellberg et al are 62% and 82%.
All investigators, however, found that patients with CIN
reported, on average, more sexual partners than did the normal
controls. The difference was not always statistically significant.
It can be seen from table 6 that, again, cases and controls
within each group studied tend to be more similar than cases or
controls from different groups, in terms of age at coitarche. Thus
55% of controls and 70% of patients with CIN questioned by Hellberg
Table5





















































































A comparison of the results of 5 epidemiological studies of patients
with CIN and normal controls










La Vecchia et al x< 17 9 21 N.S. when
(1984) 18--22 48 49 for number
> 23 43 31 partners
(n=1758) (n=124)
Zaninetti et al 14 9 14
(1986) 15 20 21


















Vonka et al -£17
(1984) 18 p < 0.05













Hellberg et al 14 14 22
(1986) 15 41 48 p < 0.01
16--19 36 23
> 20 9 7 (t. test)
N.S. = not significant
n = number of patients
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et al were 15 or younger when they started to have sexual
intercourse while only 9% of controls and 21% of CIN patients in
the La Vecchia et al study were 17 or younger at the commencement
of sexual activity. There was a trend (corresponding to that seen
in relation to number of partners) for CIN patients to have been
younger than control patients at coitarche, but this was
significant in only two of the studies.
Table 7 contains data concerning smoking from four of the five
studies. Again, considerable differences can be seen between
countries.
Clinical data obtained from lymphoma patients is contained in
Chapter 6.
Discussion
The data presented here was collected in order to discover
whether or not women with CIN living in South-East Scotland share
epidemiological characteristics with patients with CIN living
elsewhere, and to see whether it was possible to separate these
women from "normal" controls on the basis of epidemiological
features. As discussed earlier in this chapter, women with CIN in
Italy, Sweden, Czechslovakia and Scotland differ considerably from
one another in terms of sexual behaviour. It is clear, therefore,
that epidemiological data acquired from one country cannot be used
to calculate the relative risk of CIN elsewhere and that
epidemiological information including age at coitarche and number
of sexual partners should be collected from controls and cases
drawn from the same population.
It is interesting, however, to note that the incidence of
cervical carcinoma in Sweden in the 1970s was almost twice as high
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Table 7
A comparison of the results of 4 epidemiological studies
of patients with CIN and normal controls
c) smoking history
current smoking
Study Controls (%) CIN patients (%)
Zaninetti et al (1986) 55 49
Vonka et al (1984) 15 25
Hughes (1988) 51 59
Hellberg et al (1986) 41 69
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as in Scotland (annual incidence per 100,000 females 17.7 in Sweden
and 10.1 in Scotland - Waterhouse et al, 1976. The equivalent
Italian figure is not available) and to note that Hellberg et al
(1986) reported that normal controls in Sweden had had more sexual
partners and were younger when they became sexually active than the
Scottish patients with CIN in this study. It is tempting to
speculate that this difference in sexual behaviour is responsible
for the higher incidence of cervical carcinoma in Sweden. Of
course, other factors such as screening policies must also be
considered. Sweden does, however, have a well organised cervical
screening programme which was in existence in 1973 (Laara et al,
1987) and which covers a larger proportion of the population than
is covered in Scotland (Laara et al, 1987 and Scottish Health
Statistics, Advance Table, 1987) so that poor screening cannot be
blamed for the higher incidence of cervical carcinoma in Sweden.
Information concerning the male partner's sexual history was
not obtained for this study, or for the other surveys discussed
above. This is an important gap, as evidenced by the high rate of
cervical cancer in South America where the majority of women have
only one sexual partner (see Chapter 1 "The epidemiology of
squamous carcinoma of the uterine cervix").
It should be noted that in the present study no significant
difference was detected between the normal controls and the
patients with cervical HPV infections and cervical neoplasia, in
terms of parity and sexual parameters. The controls in group A
cannot be regarded as entirely normal as there had been sufficient
clinical concern about all of them (because their cervix appeared
abnormal, or because of intermenstrual bleeding) to warrant
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referral to the Colposcopy Clinic. The group *C' controls can,
however be regarded as normal controls, and it is interesting
that they did not differ significantly from patients with CIN, in
terms of sexual history. As discussed in the Results section of
this chapter, the difference in number of sexual partners reported
by cases and controls in the four other studies cited was often
relatively small and would not have achieved statistical
significance if the numbers studied had been smaller, while the
difference in age at coitarche was not significant in two of the
studies. Significantly more patients with CIN III and invasive
disease than control were cigarette smokers. No attempt has been
made here to adjust for sexual history. Nevertheless, this finding
adds further support to the increasingly popular contention that
cigarette smoking plays a significant role in the aetiology of




LOCAL IMMUNE INTERACTIONS AND MAJOR HISTOCOMPATIBILITY CLASS II
EXPRESSION IN THE CERVICAL TRANSFORMATION ZONE.
Introduction
The nature of an effective immune response to papillomavirus
infections is not well understood, although cell-mediated immunity
is thought to be more important than humoral immunity (Thivolet et
al, 1982). It is possible that a deficient immune response to human
papillomavirus (HPV) contributes towards the development of
neoplasia. The Langerhans cell (LC) is the predominant antigen
presenting cell (APC) in cervical epithelium and koilocytic and
neoplastic cervical epithelium has been shown by some authors to
contain fewer LC than normal cervical epithelium (see Chapter 1
"Langerhans cells in HPV induced lesions and in cervical
neoplasia"). The ability of the LC to present foreign antigen to
T-lymphocytes is dependent on the expression of surface MHC class
II antigens (Pehamberger et al, 1983), the level of which is known
to be variable (Berman et al, 1985) and which reflects the state of
"activation" of the cell.
The purpose of the experiments outlined in this chapter was to
relate the number, distribution and morphology of LC and their
expression of MHC Class II antigens to the presence of HPV infection
and of CIN I-III. The number and phenotype of T cells were
examined in relation to these epithelial abnormalities.
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Results
Distribution and number of LC
In specimens taken from normal cervical transformation zones
LC were found predominantly in the lower half of the epithelium
[figures 16 and 17]. The slender dendritic processes stained
strongly with DAKO T6 and appeared to link adjacent LC [see figure
6]. No significant differences in LC morphology, distribution,
number or MHC Class II expression were seen if biopsy samples from
the two groups ('A' and 'B') of normal controls were compared. In
specimens taken from areas of CIN [figures 18 and 19] LC were
distributed throughout the entire thickness of the epithelium and
their dendrites were much shorter and less numerous. Figure 20
demonstrates that T6 positive LC were significantly reduced in
number (P < 0.01) in all abnormal groups except CIN I.
Expression of MHC class II antigens by LC
When the mab DA6.231 was used the number of positively
staining dendritic cells closely paralleled the number of T6
positive cells although it can be seen from Figure 20 and Table 8
that T6 positive dendritic cells always exceeded DA6.231 positive
dendritic cells in number. Some LC present were therefore not
expressing Class II antigens, or were expressing these antigens at
undetectable levels. In each specimen there were some DA6.231
positive, T6 negative, non- dendritic cells and these were assumed
to be activated T lymphocytes. This was confirmed in some cases
(see below) by the use of mabs to T cell markers.
Table 8 shows the pattern of expression of HLA-DP, -DQ and -DR
by LC. A significantly higher percentage of LC in HPV infected























Figures 16 and 17. DAK0-T6 staining of normal cervical
transformation zone showing dendritic
Langerhans cells in the lower half of
the epithelium (magnification x 125).
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Figures 18 and 19. DAK0-T6 staining of CIN I showing Langerhans


























□ T6 positive cells
DA6 231 positive cells
(n=19)
CIN III
Bars represent mean value + S.E.M. in each group. The "normal" group
consists of five group 'A' and three group ?B' histologically normal
controls. It contains two biopsy specimens which were subsequently
analysed by flow cytometry and found to be HPV antigen negative. The
remaining six specimens were histologically normal but were not
tested for HPV antigen. The "HPV only" group includes six biopsy
specimens with histological evidence of HPV infection, without CIN,
and one histologically normal biopsy specimen, which was HPV antigen
positive. All abnormal groups, except CIN I, contain significantly
fewer T6 positive and DA6.231 positive dendritic cells per mm2
sectional area than the normal group (p < 0.01). Significance
calculated by Mann-Whitney U-test.
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Table 8
Percentage of LC (T6-positive dendritic cells) expressing
MHC class II antigens in normal and abnormal cervical epithelium
+
DA6.231 DR DP DQ
(range)% mean (range)% mean (range
53 42 19





































(n = 11) (53 - 92)
n = number of patients
+
The percentage of LC staining positively with each MHC Class II mab was
calculated for individual specimens before obtaining a mean value.
++
The "normal" group consists of three group 'A' and three group 'B'
histologically normal controls. It contains two biopsy specimens which
were analysed subsequently by flow cytometry and found to be HPV
antigen negative. The remaining four specimens were histologically
normal but were not tested for HPV antigen. The "HPV infection" group
includes four biopsy specimens with histological evidence of HPV
infection, without CIN, and one histologically normal biopsy specimen,
which was HPV antigen positive.
ic
Significance of differences compared with normal group; p < 0.05;
p < 0.01 (Mann-Whitney U-test)
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was made with HLA-DR expression by LC in normal cervical epithelium
(p < 0.05). No increase in HLA-DQ expression by LC was seen in
in the presence of HPV infection but significantly more LC were
HLA-DQ positive in all grades of CIN than in normal epithelium (CIN
I p < 0.01; CIN II and III p < 0.05). Significantly more LC were
DP positive in CIN III than in normal epithelium (p < 0.05) but the
increases seen in CIN I and II were not statistically significant.
There was a reduction in HLA-DP expression by LC in HPV infection
which reached significance (p < 0.05).
Comparison of LC numbers in the cervical transformation zone of
combined oral contraceptive pill (OCP) users and non-QCP users
In Figure 21, a comparison of LC numbers in OCP users and
non-OCP users can be seen. The number of LC was higher in OCP
users than in non-OCP users in the normal and in all the abnormal
groups, but the difference was significant only in CIN I (p < 0.05).
Comparison of LC numbers in the cervical transformation zone of
smokers and non-smokers
In Figure 22, a comparison of LC numbers in current smokers
and non-smokers can be seen. There was no significant difference
between LC numbers in smokers and non-smokers in any group. When
heavy (20 or more cigarettes per day) smokers were compared to
non-smokers there was again no significant difference.
Relationship of LC counts to clinical outcome
Of the 21 patients with CIN I studied in this section, 10 were
recruited to a study being performed at the Lothian Area Colposcopy
Clinic, comparing the outcome in patients who receive laser
treatment for CIN I or for cervical HPV infection, with the outcome
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The "normal" group consists of four group 'A' and four group 'B'
histologically normal controls. It contains two specimens which were
analysed subsequently by flow cytometry and found to be HPV antigen
negative. The remaining six specimens were not tested for HPV
antigen. The "HPV only" group includes seven specimens with
histological evidence of HPV infection and two histologically normal
specimens which were HPV antigen positive. Bars represent mean value
+ S.E.M. in each group. OCP users did not differ significantly from
non-OCP users within any group except in CIN I (p < 0.05).
























(n=3 Xn=4) (n=2 Xn=7) (n=13Xn=10) (n=Un=8) (n=7 Xn=18)
normal HPVonly CINI CINII CINIII
The "normal" group consists of three group 'A' and four group 'B'
controls histologically normal controls. It contains two specimens
which were analysed subsequently for HPV antigen and found to be
negative. The remaining five specimens were not tested for HPV
antigen. The "HPV only" group includes seven specimens with
histological evidence of HPV infection, and two histologically normal
specimens which were HPV antigen positive. Bars represent mean value
+ S.E.M. in each group. Smokers did not differ significantly from
non-smokers within any group. Significance calculated by Mann-Whitney
U-test.
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Six of the 10 were randomised to receive no treatment or to use
condoms and of these six, two (who had been advised to use condoms
but who had not used them consistently) had CIN III when they
were re-examined one year after the biopsy analysed in this study
was taken. Four patients were randomised to receive laser
treatment and 11 others were excluded from the study and received
laser or cold coagulation treatment. One year follow up data is
available for two of the other four women who received no
treatment. These two women have persistent CIN I. The mean LC
2
count /mm for the "progressors" (n=2) was 11 (range 6-16), for the
patients with persistent CIN I (n=2) 37 (range 24-50) and for the
patients (n=8) who had no evidence of residual disease after laser
or cold coagulation treatment 39 (range 5-77). These differences
are not statistically significant (Mann-Whitney U test). One year
follow up information is available for six women with treated CIN
II; none of these women had colposcopic evidence of residual or
recurrent disease.
Follow up data is available on 18 women with treated CIN III;
four (22%) of these patients had residual or recurrent CIN. The
2
mean LC count /mm (in the original biopsy) for patients with CIN
after treatment for CIN III was 8 (range 3-45) and for the patients
with no evidence of recurrence 14 (range 2-58). This difference
is not statistically significant (Mann-Whitney U test).
T cell numbers
In this section T cell counts in abnormal cervical TZ
epithelium were compared with T cell counts in normal cervical
epithelium. The abnormal cases were categorised as either
HPV infection alone (without associated CIN) (n=4); CIN in which
Table9
























(4-42)12103)(0.340.98 16220.734 (11-30)556(0.41. 3)34 19280.69 (3-36)15-780.521.43)4 19380.5224 (4-33)9-820. 2.86)57
AAcells/mm2 The'normal'groupconsistsftw'A dr'Bhist logically normalcontrols.Ic ntainsespecimenwh cha alys dsubsequently forHPVantigenndoutobenegative.Thr maininghresp cime sw r nottestedforHPVantigen, n=umberofpatients Nomeanvalueobtainedfr manormalgr upw ssignificantlydiffe e tfr thecorrespondingm aninormalg oup(Mann-WhitneyUte t)
108.
the number of HLA-DR positive LC exceeded the number of HLA-DQ
positive LC (n=5); and CIN in which the number of HLA-DQ positive
LC exceeded the number of HLA-DR positive LC (n=3).
It can be seen from table 9 that the total number of T cells
(as measured by counting cells expressing the T cell common
antigen, CD3) was insignificantly reduced from normal in koilocytic
lesions. In CIN the count was intermediate between the counts in
normal epithelium and koilocytic lesions. CD8 positive T cell
(suppressor/cytotoxic T cell) counts exceeded CD4 positive T cell
(helper/inducer) counts within normal and abnormal epithelium and
there was no significant difference between the CD4:CD8 ratios in
the normal and any of the abnormal groups. There was an
insignificant trend for CD8 positive T cell numbers to be reduced
to a greater extent than CD4 positive T cell numbers in the
koilocytosis only and CIN (HLA-DQ <DR) groups, making the CD4:CD8
ratios higher in these groups. There was no significant difference
in T cell counts between the CIN (HLA-DQ < DR) and CIN (HLA-DR <
DQ) groups. If the CIN (HLA-DR < DQ) group (which contained only
cases of CIN I) was compared with the two cases of CIN I in the CIN
(HLA-DQ < DR) group, no significant difference was identified.
Expression of MHC class II antigens by columnar and squamous
cervical epithelium
In three of ten specimens from normal transformation zones and
16 of 67 specimens from abnormal transformation zones a portion of
columnar epithelium was included in the sections. In all 19 cases
this epithelium stained positively with DA6.231 [figure 23] but not
with the other mabs.
Normal squamous epithelium from the transformation zone and
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Figure 23. DA6.231 staining of endocervical columnar epithelium;
adjacent squamous epithelium is negative (magnification x 125).
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specimens of squamous epithelium from areas of koilocytosis only,
and of CIN I and II, were consistently negative with all mabs used.
In four of 29 (14%) specimens of CIN III positive staining of
squamous epithelium was seen using DA6.231, with parabasal cells
staining particularly strongly [figure 24]. Staining with other
mabs was always negative. These four cases were excluded when
DA6.231 positive LC were being counted, as it was not possible to




The choice of control patients for comparison with patients
with HPV infection and with CIN in this and subsequent sections was
not ideal. It is recognised that a larger number of normal
controls should have been included. In addition, all controls
should have undergone colposcopic examination, in view of the well
recognised insensitivity of cervical cytology (Coppleson, 1970 and
Giles et al 1988). All specimens should have been tested for HPV
antigen or viral DNA, as it is now appreciated that a significant
proportion of colposcopically, cytologically and histologically
normal cervices contain HPV DNA (Wickenden et al 1985). Ideally the
group 'C' controls should have been included in this section.
Unfortunately it was not possible to recruit these control patients
until after most of the experimental work had been completed.
It is, however, noteworthy that despite these deficiencies it
was still possible to demonstrate a significant difference in terms
of LC numbers and MHC Class II expression between patients with
proven HPV infection and CIN, and "normal" controls. The lack of
111.
Figure 24. CIN III stained with DA6.231 (magnification x 250).
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colposcopic and HPV antigen screening of controls may have led to
the inclusion of some patients with HPV infection and CIN in the
control group. However it can be predicted that the inclusion of
these patients would diminish any differences between controls and
patients, thus weakening rather than strenthening the data.
Distribution and numbers of LC and T cells
The work reported here demonstrates that LC are reduced in
number in HPV lesions and in CIN II and III, and that their
distribution and morphology are altered within abnormal cervical
epithelium. This is consistent with a recent report from Tay et al
(1987a) although earlier studies reported a decrease in LC numbers
in HPV lesions and an increase in numbers in CIN (Morris et al.
1983; McArdle and Muller, 1986).
The reduction in LC numbers and alteration in morphology may
be responsible for the reduction in T cell numbers in CIN, and the
more marked reduction in T cells in koilocytic lesions relative to
normal reported here and elsewhere (Tay et al, 1987b).
It has been postulated (Morris et al, 1983) that the
papillomavirus exerts a direct cytotoxic effect upon LC and the
loss of dendrites observed here may be a reflection of this effect.
It is interesting to note the abnormal distribution of LC
throughout dysplastic epithelium and to speculate upon the
relationship between this and the pattern of HPV infection of
squamous epithelium. HPV DNA can be detected by in situ
hybridisation in the parabasal layers but viral antigens are
normally detected only in the more superficial layers of the
epithelium (Kurman et al, 1983). Perhaps the antigen positive
cells attract LCs towards the surface away from their normal
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parabasal position. Once at the site of infection LCs may be able
to present HPV antigens locally to T lymphocytes or, having been
activated by the local viral infection, may leave the site and
present HPV antigens in draining lymph nodes. An experiment
designed to investigate the latter possibility is described in
Chapter 5.
MHC class II expression by LC
In figure 11 it can be seen that not all T6-positive LC were
stained with the pan-Class II marker, DA6.231. This has been
reported previously (Chardonnet et al, 1986; Tay et al, 1987a;
Harrist et al, 1983) using other mabs to Class II antigens, and may
reflect the variable expression of these antigens by LC. HLA-DR
expression by LC was significantly increased in koilocytic lesions,
and in CIN I and II, and HLA-DQ expression was significantly
increased in all grades of CIN with the increase being most marked
in CIN I (see Table 8). Thus, although LC are reduced in number
compared to normal, those present appear more highly "activated".
The parallel increase in HLA-DR and -DQ expression by LC in
CIN is consistent with reports from other groups that HLA-DQ
expression correlates in general with HLA-DR expression (Sorrentino
and Corte, 1986). HLA-DQ is almost always expressed at a much lower
level than HLA-DR (Sorrentino and Corte, 1986), so that detection
of HLA-DR positive HLA-DQ negative cells may reflect the limit in
sensitivity of the technique used.
Most published work suggests that the expression of HLA-DQ and
HLA-DP antigens has the same functional significance as the
expression of HLA-DR (Gonwa et al, 1983; Nunez et al, 1985;
Sanchez-Perez and Shaw 1986). However Navarette et al (1985a and
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1985b) have proposed that HLA-DQ has a function distinct from
HLA-DR. They report that, while HLA-DR is implicated in the
induction of the proliferation of helper/inducer T lymphocytes,
HLA-DQ has a predominantly modulatory function involving the
generation of suppressor and/or cytotoxic T lymphocytes. This may
be of relevance to the present study as a small, insignificant,
increase in the relative proportion of CD8 positive T cells was
found in the cases where HLA-DQ positive LC exceeded HLA-DR
positive LC in number. The number of patients studied was too
small for this increase to achieve statistical significance but it
is noteworthy that Tay et al (1987b) report an increase in the
relative proportion of CD8 positive T cells in CIN. In the
present study increased HLA-DQ expression by LC was found to be
particularly marked in CIN I. It is possible that the
presentation of viral and/or tumour antigens together with HLA-DQ
early in the development of CIN (i.e. in CIN I) leads to a
predominantly suppressor type response specific for these antigens,
thus permitting the disease to progress more rapidly.
HLA-DP specific antibodies have only recently become
available so that there is little reliable information on the
expression of HLA-DP. The data available suggests that HLA-DP
expression is qualitatively indistinguishable from DR
(Sanchez-Perez and Shaw, 1986) and the work reported here would
support that hypothesis.
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Combined oral contraceptive pill (OCP) use and LC numbers
In this section LC were found to be increased in number in the
epithelium of the cervical transformation zone of OCP users, when
compared to non-OCP users, with the increase reaching significance
in patients with CIN I [figure 21]. This has not been previously
reported although other workers have demonstrated an impairment of
non-specific peripheral blood lymphocyte proliferation in OCP users
(Barnes et al, 1974) and an elevation of cervical mucus IgG and IgA
in OCP users (Chipperfield and Evans, 1972). Perhaps the
increased numbers of LC present are involved in the initiation and
amplification of a local antibody response in the cervix. It is,
in any case, interesting to note a difference between OCP users and
non-OCP users in view of the continuing controversy over the role
of the OCP in the aetiology of cervical cancer (Piper, 1985;
Francheschi et al, 1986).
Cigarette smoking and LC numbers
No significant difference in LC numbers was found between
smokers and non-smokers, in normal or abnormal cervical epithelium.
This is in contrast with the recently published work of Barton et al
(1988) who found that LC numbers were significantly reduced in the
cervices of smokers. Further work will be necessary to clarify
this discrepancy.
Relationship of LC counts to clinical outcome
The results obtained concerning clinical outcome show that
there is a trend for women with progressive disease or with
recurrence after ablative therapy to have lower LC counts at their
first visit. The numbers in each group are too small for this
trend to be statistically significant but the finding adds further
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support to the hypothesis that LC play an important role in
immunosurveillance against neoplastic change within cervical
epithelium.
Expression of MHC class II antigens by columnar and squamous
cervical epithelium
The expression of class II antigens by columnar epithelium
lining endocervical glands was a chance finding as the majority of
sections studied contained no columnar epithelium. Expression of
HLA-DR by endometrium has been reported to vary with the menstrual
cycle (Tabibzadeh et al, 1986a) being highest in the late
proliferative phase and thus correlating with oestrogen receptors
levels. No apparent correlation between intensity of staining and
stage of the menstrual cycle was found in the present study but 11
of 19 subjects in this group were OCP users and therefore not
experiencing normal cycles. It would be useful to examine this in
more detail.
It was interesting that in some cases (14%) of CIN III the
squamous epithelium exhibited positive staining with DA6.231
although no epithelium from normal cervix or from areas of CIN I or
II was positive. Morris et al (1983) reported HLA-DR expression
by squamous epithelial cells in CIN III and, in patches, in
koilocytic lesions with no associated CIN. It is postulated that
keratinocytes (Lampert, 1984) and endometrial epithelial cells
(Tabibzadeh et al, 1986b) are induced to express class II antigens
by lymphokines secreted by infiltrating lymphocytes and thus
acquire the ability to act as antigen presenting cells. The
detection in this study of class II positive epithelial cells in
CIN III may be further evidence to support this hypothesis.
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Functional assays should bring further understanding of the
interactions taking place between LC, lymphocytes and epithelial
cells in the cervical transformation zone and of the significance




FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT C-MYC PROTEIN EXPRESSION AND
PAPILLOMAVIRUS ANTIGEN EXPRESSION IN CERVICAL EPITHELIUM
Introduction
In this section the technique of flow cytometry was employed
to analyse patterns of cell division and to look for evidence of
DNA aneuploidy in HPV infected and neoplastic cervical epithelium.
Aneuploidy is a well recognised characteristic of malignancy
(Friedlander et al, 1984a) and it is known that the number of
proliferating cells in a tumour increases in parallel with
neoplastic change (Laerum and Farsund, 1981).
The techniques of cervical brushing and biopsy to obtain
specimens for flow cytometry were compared. The relationship
between expression of papillomavirus antigens and the rate of cell
division was compared in view of the hypothesis that the
papillomavirus acts as a nonspecific mitogen (Reid et al, 1982).
C-myc oncogene protein expression was also examined, and expression
related to grade of CIN and rate of cell division.
Results
Comparison of cervical brushings and biopsy specimens
10^ - 5 x 10^ (mean 2 x 10^) nuclei were obtained from a
biopsy specimen and 0.6 x 10^ - 6 x 10^ (mean 1.6 x 10^) from a
brush specimen. More cells were obtained by brushing mid cycle
than peri-menstrually. Twelve patients (four normal, two with
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koilocytosis only, two with CIN I, one with CIN II and three with
CIN III) had both brushings and a cervical biopsy specimen taken
for flow cytometric analysis, to compare the two methods of
obtaining samples. Propidium iodide staining gave very similar
results from both brushings and biopsies; if the % S + + M phase
values obtained from a biopsy and brush specimen in each patient
were compared the difference was never more than 3%. A DNA
%
aneuploid population was identified in one biopsy specimen; DNA
aneuploidy was also detected in the brush specimen from the same
patient and no other aneuploid populations were detected in
biopsies or brushings from this group.
When c-myc oncogene expression was measured using the antibody
MYC-6E10, results from biopsies and brushings from the same patient
did not differ by more than 2%.
The percentage of papillomavirus antigen positive nuclei in
biopsies and brushings from the same patient varied considerably
(see below).
Comparison of different methods of fixation of brush specimens
Two brush specimens were taken from six patients (four normal,
two with CIN I) and one specimen fixed in methanol while the other
specimen was fixed in 1% formol saline, in order to determine
whether these different methods of fixation gave different results
with propidium iodide, c-myc or papillomavirus antigen staining. No
significant difference was detected when the two methods of
fixation were compared, for any of the above stains.
Results
Cell cycle analysis
Table 10 shows that of 89 cervical biopsy samples examined,
Table10
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nine were classified by histopathological criteria as normal
squamous epithelium, 12 as containing evidence of HPV infection
without CIN, and 68 as showing evidence of CIN; 14 grade I, 21
grade II and 33 grade III. Table 11 shows that brushings were
taken from five cytologically, colposcopically and histologically
normal cervices, seven cervices containing evidence of HPV
infection without CIN, six containing CIN I, five containing CIN II
and six containing CIN III. Four biopsy specimens and three brush
specimens produced histograms on flow cytometry that, because of an
abnormal distribution of DNA were unsuitable for parametric
analysis and were omitted from this part of the study. Tables 10
and 1 1 also show the proportion of nuclei in the S phase and in the
S + + M phases of the cell cycle.
Traditionally, studies of cellular proliferation have examined
only the fraction of cells in the S phase, as the cells in the +
M phases could not be quantitated by the uptake of tritiated
thymidine. In this study it was found that calculating the total
proportion of cells in the S + + M phases gave more consistent
results than calculating the proportion of cells in the S phase
alone, although as can be seen from tables 10 and 11 the two
measurements gave very similar results.
The percentage of nuclei in the S phase increased from 11%
(biopsy specimens) and 9% (brush specimens) in normal cervix to
20% (biopsy specimens) and 21% (brush specimens) in epithelium
containing evidence of HPV infection ( p < 0.05). The samples
(biopsy and brush) from patients with CIN all contained
significantly more cells in the S phase than those from the normal
controls. There were no significant differences between the group
Table11
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with evidence of HPV infection only and the group with CIN. When
the S and G^ + M phases were considered together a similar pattern
was seen. Biopsy and brush samples from all four groups with
abnormalities (HPV infection and CIN I, II and III) contained
significantly more cells in the S + G^ + M phases than the normal
control samples but did not differ significantly from each other.
DNA aneuploidy
DNA aneuploidy was classified in two ways: (a) and (b).
(a) The DNA index was calculated from the ratio between the
chicken red blood cell (CRBC) and sample modal channel numbers
versus the ratio between the CRBC and lymphocyte modal channel
numbers (Vindelov et al, 1983). Thus a DNA index of 1 equalled
the DNA index of a diploid cell. A sample was considered to
contain a DNA aneuploid component by this classification if the DNA
index was less than 0.9 or more than 1.1. Column (a) in tables 10
and 11 contains results obtained according to this classification.
All four abnormal groups yielded some aneuploid biopsy samples, the
proportion of aneuploid specimens ranging from 14% (CIN I) to 21%
(CIN III). Seventeen per cent of "HPV infection only" biopsy samples
contained an aneuploid component. Brush specimens gave very
similar results; the proportion of aneuploid brush specimens
ranging from 13% (CIN I and III) to 20% (CIN II). No DNA
aneuploidy was detected in brushings taken from cervices containing
evidence of HPV infection. Of the 17 aneuploid samples identified
(15 biopsy samples,two brush samples and one brush and biopsy from
the same patient), seven were hypodiploid (DNA index < 0.9) and ten
were hyperdiploid (DNA index > 1.1). The DNA index of
hyperdiploid cell populations was always less than 1.5.
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For a more detailed analysis of the detection of aneuploidy in
brushings and biopsy specimens see "Comparison of cervical
brushings and biopsy specimens" above.
(b) It has been suggested that DNA aneuploidy should be reported
only when at least two separate Gq/G^ peaks are demonstrated
(Hiddemann et al, 1984) [see figure 25]. Column (b) in tables 10
and 11 contains the results obtained when DNA aneuploidy was
classified in this way. It can be seen from table 10 that this
method leads to a smaller percentage of specimens being reported as
containing an aneuploid component than method (a), with the
fractions ranging from 7% (CIN I and II) to 17% (HPV infection
only). When brush specimens were classified by the two different
methods the results obtained were identical (table 11).
Relationship of flow cytometric findings to clinical outcome
The majority of patients studied in this section received
local ablative therapy to the cervical transformation zone either
immediately after the biopsy or brushing was taken or between two
and nine weeks later. Four patients with HPV infection only and
three patients with CIN I received no treatment or were asked to
use condoms as part of the trial described above (see "Relationship
of LC count to clinical outcome"). One year follow-up data is
available for 78 of the 106 patients. Of these 78, 10 had residual
or recurrent disease after treatment, and one had
progressed (without treatment) from HPV infection only at her first
visit to CIN III one year later. When cell cycle data on the
original biopsies or brushings from the patients with disease at
one year was compared with data on the disease-free patients at one




























Figures 25a and b DNA histogram of aneuploid sample of CIN III
(LFRL = log red fluorescence, G /G (A) and G + M
(A) denote the aneuploid components}.
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a DNA aneuploid component was detected were compared with samples
in which no aneuploid component was detected, again, no significant
difference in clinical outcome was detected. Of _67_ patients with
non-aneuploid specimens on which one year follow up data was
available six (9%) had evidence of residual or recurrent disease.
Follow up data was available for 11 patients who had had evidence
of aneuploidy; of these, one patient had further CIN after
treatment (for CIN III) and one patient (who had had HPV infection
only originally) now had CIN III. This equals a recurrence or
progression rate of 18% (2/11). The other "HPV infection only"
patient with evidence of DNA aneuploidy had previously had CIN III
treated by laser.
C-myc protein staining
The number of specimens in each histological category staining
positively with the anti-c-myc antibody MYC1-6E10 is shown in table
12. It can be seen that the percentage of specimens from normal
cervical epithelium which were c-myc antigen positive was higher
(63%) than the percentage of specimens from CIN II or III (20%) or
invasive carcinomas (0%). These differences were not significant
by Fisher's exact probability test at P < 0.05 although the
difference between normal and invasive carcinoma does reach
significance at the P < 0.2 level. The range of percentages of
nuclei staining positively with MYC1-6E10 (in the positive
specimens) is also shown. If c-myc antigen positive specimens in
each histological group are compared the percentage of nuclei in
each specimen staining positively does not vary by more than 2.3%
(table 12).
The percentage of nuclei in the S and G2 + M phases of the
Table12
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cell cycle in c-myc antigen negative and c-myc positive specimens
is shown in table 13. It can be seen that within each histological
group, there was no significant difference in the percentage of
cells in the S and G2 + M phases of the cell cycle when c-myc
negative and c-myc positive specimens were compared.
HPV antigen staining
The results obtained from staining cervical nuclei with an
antibody to papillomavirus antigens are displayed in table 14. It
can be seen that the proportion of specimens exhibiting positive
staining with the antibody ranged from 38% (normal cervices) to 83%
(koilocytosis alone). A similar proportion of biopsies and
brushings from CIN with (67%) and without (75%) associated
koilocytosis stained positively with the antibody. Nine patients
had both a biopsy sample and a brush sample tested for the presence
of papillomavirus antigen. In seven patients both the brush
specimen and the biopsy specimen stained positively; in one
patient both were negative, while in one patient with a
cytologically, colposcopically and histologically normal cervix the
biopsy gave a negative result while the brushing stained positively
with antibody to papillomavirus antigens.
When the percentage of nuclei from brush and biopsy samples
staining positively with the antibody were compared it can be seen
from table 14 that brush samples gave consistently higher
percentages than biopsy samples. HPV antigen positive brush
samples from the different histological groups did not contain
significantly different percentages of positive nuclei; similarly
there was no significant difference between the HPV antigen positive
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The percentage of cells in the S + + M phases of the cell
cycle in HPV negative and positive specimens is shown in table 15.
It can be seen that within each group except CIN with koilocytosis,
HPV positive specimens contained more dividing cells than HPV
negative specimens. The differences were not significant by the
Mann-Whitney U test; perhaps because of the small numbers in the
HPV negative groups.
The results obtained from staining six specimens of prostatic
chippings obtained at transurethral resection of prostate are shown
in table 14. No positive staining was obtained with anti-papilloma
virus antibody in these specimens.
The results obtained by staining biopsies from cervical
carcinomas, from adjacent normal or dysplastic epithelium and from
draining internal and external iliac lymph nodes with antibody to
papillomaviral antigens are shown in table 16. It can be seen
that no carcinoma specimens stained positively with this antibody
and that 50% of specimens from adjacent normal cervical epithelium,
67% from adjacent dysplastic epithelium and 73% of draining lymph
nodes stained positively. Where both a cervical biopsy and a
lymph node specimen were examined the lymph node contained a higher
percentage of HPV antigen positive nuclei than the corresponding
cervical biopsy, except in one case.
Three of the 11 lymph node specimens tested contained
metastatic tumour. Two of these specimens were HPV antigen
positive, and one was HPV antigen negative.
Discussion
The normal controls
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made here as were made in chapter 4 (p. 110). However, it should be
stressed again that the possible inclusion of patients with HPV
infection or CIN in the control group would have the effect of
weakening rather than strengthening the reported data, so that the
actual differences between controls and patients may be greater than
found here.
Comparison of cervical brushings and biopsy specimens
A number of authors have advocated the use of cervical brushes
for obtaining specimens for routine cytopathology (Glenthoj et al,
1986), tor HPV UNA extraction (McCance eL al, 198Gb) and for flow
cytometric analysis (Elias-Jones et al, 1986). The data obtained
in the present study show that cervical brush specimens give very
similar results when analysed for DNA content and for expression of
the c-myc oncogene product as cervical biopsy specimens, and thus
offer a non-invasive alternative to biopsies which causes less
discomfort to the patient and is less likely to alter the natural
history of cervical lesions.
The results concerning HPV antigen expression obtained from
brushings did differ from those obtained from biopsies, in that the
percentage of positive nuclei within positive samples was higher in
brushings than in biopsies. This is presumably a sampling effect as
a brush removes mainly superficial epithelial cells which are more
likely to be antigen positive (Kurman et al, 1983) while a biopsy
normally removes the full epithelial thickness as well as some
underlying stromal cells. Theoretically a brush sample may be
preferable as a brush obtains only epithelial cells without the
stromal contamination which is inevitable in a biopsy specimen.
This contamination might be avoided by employing a technique
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similar to that described by Caorsi and Figueroa (1986), in which
cervical biopsies are incubated in EDTA, a chelating agent which
facilitates the separation of epithelium from stroma. The use of
this refinement would help clarify whether the changes described
above in biopsy specimens from HPV infected and neoplastic cervices
do relate to the epithelium or are due to changes in the cell
population of the underlying stroma. Despite this, when biopsy
and brush samples were taken from the same patient the two samples
gave the same result (i.e, either HPV positive or negative) as one
another in eight of nine patients.
Cell cycle analysis
The analysis of cellular DNA content by flow cytometry shows
that normal cervical epithelium can be distinguished from HPV
infected epithelium and from epithelium containing CIN. HPV
infected or dysplastic epithelium differed from normal in
containing a larger proportion of dividing cells (cells in the S
and G2 + M phases) and, in some cases, in possessing a DNA
aneuploid component (see below).
It has been postulated that cells infected with HPV initially
behave as though stimulated by a non-specific mitogen and that in a
semi-permissive epithelium many cells remain in a prolonged S or G2
phase (Reid et al, 1982). Reid (1983) proposed that cumulative
mitotic errors in these stem cells might result in occasional
chromosomal mutations spawning clones of aneuploid basal cells. By
showing an increased proportion of cells in the S + G2 + M phases
in the koilocytic group and in the HPV antigen positive groups the
data presented here support this view. The biopsy samples from
CIN II and III contained a smaller proportion of S phase cells than
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samples from HPV infected lesions and from CIN I, although this
difference was not significant, and was not parallelled by a
similar decrease when the S and + M phases are considered
together. The reduction of S phase cells in CIN II and III
relative to CIN I and HPV infected lesions is consistent with
Reid's hypothesis that the papillomavirus initially stimulates
epithelial proliferation followed by S phase arrest and the
emergence of aneuploidy.
DNA aneuploidy
The proportion of samples containing DNA aneuploid populations
was essentially similar in the four abnormal groups, including the
group with HPV infection alone (range 14.4% to 21.2% by the criteria
of Vindelov et al, 1983). The prevalence of aneuploidy in CIN III
reported here is considerably lower than that reported by Jakobsen
et al (1983) and Reid et al (1984). This may be due to
differences in the preparation of specimens, in the sensitivity of
the various methods or in the definition of aneuploidy.
Hendy-Ibbs et al (1987), defining aneuploidy as "the presence of a
distinct second peak separate from the diploid distribution" found
no aneuploidy in a series of 34 cases of CIN and 64 cases of
invasive cervical carcinoma. They noted a positive skew of the
diploid peak in 19 of the carcinoma specimens, which they suggest
could be due to aneuploidy. In the present study some of the
Gq/Gj peaks were abnormally broad and may have included an
aneuploid component merging with the diploid population. The
detection of aneuploidy in HPV infected epithelium (without
associated CIN) has recently been confirmed by other workers (Watts
et al, 1987) and Evans and Monaghan 1985, in related work using
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static cytometry, reported aneuploidy in cases of "warty atypia".
The finding would support the hypothesis that HPV plays a
significant role in the aetiology of cervical carcinoma and has
important implications for the management of patients with cervical
HPV infection and with CIN I. In many centres these patients are
treated conservatively in the hope that the lesion will regress.
It has been suggested that the clinical behaviour of these lesions
may be predicted on the basis of ploidy (Fu et al, 1983 and Evans
and Monaghan, 1985). No evidence was found for this on the basis
of results from those patients for whom follow-up data was
available (see Results section "Relationship of flow cytometric
findings to clinical outcome") but this may be related to the small
number of patients in each diagnostic group who had a follow-up
colposcopic examination after treatment as well as to the short
period of follow-up. The data presented here do, however, show
that it was not possible to distinguish koilocytic lesions from CIN
III by cell cycle analysis or by ploidy implying that they should
perhaps be treated identically.
Oncoprotein staining
It is interesting that the percentage of specimens from normal
cervical epithelium which were c-myc antigen positive was higher
than the percentage from CIN II or III or invasive carcinomas,
although not significantly so. C-myc DNA amplification has been
found in more advanced cervical carcinoma (Riou et al, 1984 and
Ocadiz et al, 1987) and increased levels of c-myc RNA are
associated with early clinical relapse in early (stage I and II)
carcinomas (Riou et al, 1987). In contrast Hendy-Ibbs et al
(1987) report a higher level of c-myc antigen expression in normal
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cervical epithelium than in neoplastic epithelium (in wax embedded
tissue) corresponding with the findings reported here. C-myc mRNA
and protein have a short half life in stimulated cells (Dani et al,
1985 and Rabbitts et al, 1985) and it has been suggested that they
may be particularly susceptible to proteolysis in neoplastic cells
during the preparation for the assay, or that MYC 1-6E10 may
recognise an epitope of some other nuclear associated proteins.
However, another antibody recognising a different region of the
protein, gave the same results (Hendy-Ibbs et al, 1987). Thus it
seems likely that MYC1-6E10 does recognise the c-myc product.
HPV antigen staining
The finding of HPV antigen expression in 38% of otherwise
normal cervices is consistent with reports published elsewhere that
between 11% (Wickenden et al, 1985; Toon et al, 1986; Lorincz ert
al, 1986) and 50% (Schneider et al, 1987) of otherwise normal
cervices contain HPV DNA. The proportion of dysplastic biopsy
specimens containing HPV positive nuclei (71% - see table 14) is
higher than is generally reported for immunohistochemical studies
of paraffin sections (Kurman et al, 1983). The method of
preparation of nuclei for flow cytometric analysis used in this
study may expose the viral antigens in a way which makes them more
accessible to antibody. The technique may also be more sensitive
than standard immunohistochemical techniques as many thousands of
nuclei can be examined very rapidly. It is possible that the
antibody used cross reacts with an epitope found in cervical
epithelium and encoded by cellular DNA, which is exposed when the
nuclei are prepared by the method described here and not in
paraffin sections. This seems unlikely, as the antibody is prepared
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by purifying viral protein from bovine rather than human
papillomas. A larger proportion of dysplastic biopsies than
normal cervical biopsies stained positively with the antibody, and
the antibody did not recognise any epitopes present in prostatic
tissue (see table 14).
The relationship between HPV antigen expression and cellular
proliferation has been discussed above.
No HPV antigen expression was detected in seven cases of stage
lb cervical carcinoma. This was not unexpected, as antigen
expression is known to decrease with increasing severity of
neoplastic lesions (Kurman et al, 1983). The identification of
papillomaviral antigens in biopsies taken from dysplastic and
normal epithelium adjacent to carcinomas was also anticipated, as
Kurman et al (1983) report antigen expression in CIN I and II
adjacent to antigen negative CIN III, while Ferenczy et al (1985)
report the presence of HPV DNA in biopsies taken from normal skin
adjacent to treated anogenital warts. The detection of viral
antigen in draining lymph nodes was, however, unexpected and has
not previously been reported. Two HPV positive nodes contained
metastatic tumour, so that the viral antigen may have been present
in metastatic tissue. The other six HPV positive nodes were,
however, free of metastasis, and it must be postulated that the
viral antigen was transported there by circulating LC or T cells.
It would be interesting to perform immunohistochemical staining or
in situ DNA hybridisation on paraffin sections of antigen positive
nodes in order to determine which cells contain viral proteins.
This would help further our understanding of the local immune
response to epithelial papillomavirus infections. It would also be
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useful to examine lymph nodes draining apparently uninvolved
epithelium, to discover if they too contain HPV antigen.





CERVICAL INTRAEPITHELIAL NEOPLASIA IN LYMPHOMA PATIENTS
Introduction
Patients with lymphomas are known to be at increased risk of
developing second malignancies, especially acute myeloid leukaemia
(Coleman et al, 1982, Tester et al, 1984) and, in the case of
patients with Hodgkin's disease (HD), non-Hodgkin's lymphomas
(Jacquillat et al, 1984). It has been suggested that the
incidence of second malignancies in HD patients correlates with the
level of treatment to which patients are exposed (Arseneau et al,
1972) and, for those receiving very intensive chemotherapy and
radiotherapy, the risk may increase by as much as 1500 times
(Coleman et al, 1982, Tester et al, 1984). There is little
evidence of an increased incidence of second malignancies in
patients treated with radiotherapy alone leading some authors to
postulate that the increase in risk is related to the use of
chemotherapeutic agents, especially alkylating agents (Anon, 1985).
These drugs are mutagenic and carcinogenic in laboratory systems
and are also immunosuppressive (Schilsky and Erlichman, 1982).
Procarbazine, an important drug in the treatment of HD, is also
highly carcinogenic in experimental systems (Schilsky and
Erlichman, 1984).
In this section a defined group of patients suffering from HD
or non-Hodgkin's lymphoma were studied in an attempt to discover
their relative risk of developing cervical neoplasia. Evidence of
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cervical HPV infection was also sought. There is some evidence that
immunosuppression may lead to the malignant conversion of
papillomavirus induced lesions in animals (Campo and Jarrett, 1987)
and in man (Sillman et al, 1984, Rudlinger et al, 1986, Schneider e_t
al, 1983).
Table 17 contains information concerning the lymphoma patients
studied. They were compared with the control patients in groups
'A' (n=12) and TC * (n=67). Those four patients in control group 'A'
who were found to have CIN or HPV infection (see p.68) were not
excluded from the control group in this section. Biopsies and/or
brushings from three group 'A' controls were known to be HPV antigen
negative. The HPV antigen status of the remaining five group 'A'
controls, and of all group 'C' controls, is unknown.
Results
a) General patient data
It can be seen from table 17 that the lymphoma patients
studied were less likely to have been pregnant and reported a later
onset of sexual activity and fewer sexual partners than the
control patients. In addition fewer of the lymphoma patients
smoked. Thirteen (48%) lymphoma patients used no contraception. In
nine patients this was because contraception was unnecessary due to
post-chemotherapy amenorrhoea which had lasted for at least 18
months. The mean age at onset of amenorrhoea was 34.5 years (range
23-44 years).
b) Haematological data
Details of haematological diagnoses are given in table 18.
All HD patients receiving chemotherapy (C/T) were given
procarbazine, prednisolone, vinblastine and/or vincristine and
Table17
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mustine or chlorambucil. Standard dosage regimens were employed.
One patient (MM) also received adriamycin. Chemotherapy for
non-Hodgkin's lymphomas consisted of cyclophosphamide, adriamycin,
vincristine and prednisolone for all patients. One patient (WT)
also received bleomycin.
Those patients who received both radiotherapy (R/T) and C/T
did so because of residual disease after initial R/T, or because
they experienced a relapse following R/T. There were two
exceptions; JJ was given R/T when she experienced a relapse
following initial C/T, and MMcK experienced profound
myelosuppression during C/T, necessitating the completion of her
treatment with R/T.
Patients with localised disease (stage 1 and sometimes stage
2) were given R/T, and only one patient (PB) received pelvic R/T.
C/T was the treatment of choice for more extensive disease. In
non-Hodgkin's lymphomas the degree of differentiation was also
considered; thus patients with low grade lymphomas received R/T and
those with higher grade tumours C/T. In general, therefore, those
patients who received C/T had more extensive and/or less
differentiated tumours than those who received R/T.
c) Previous cervical cytology
Twenty-one (78%) lymphoma patients (including four patients
found to have CIN) reported having had previously normal cervical
cytology. Smears from 16 of these patients could be traced and 15
were confirmed normal. One (from a patient found to have CIN
III) was reclassified as class 2. The mean length of time since
the last normal smear for the whole group was 67.3 months (range
5-240) and for the patients found to have CIN 16.3 months (6-45
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months).
One patient (SLeP) had had a class 1+ smear 4 months before
being seen at the Colposcopy Clinic. This smear was confirmed
class 1+ on review and a diagnosis of CIN I with koilocytosis was
made by histological examination of a colposcopically directed
punch biopsy.
d) Cervical histology
It can be seen from table 19 that five (19%) lymphoma patients
had CIN II/III, compared with two (3%) of the controls. This
2
difference is Statistically significant (p < 0.01) hy the test.
The percentages of lymphoma patients with koilocytosis alone, and
with CIN I, were not significantly greater than the percentages of
control patients with these abnormalities. Significantly more
lymphoma patients (14 patients; 52%) had evidence of cervical HPV
infection than controls (21 patients; 27%) (p < 0.02). Table 19
shows that all six lymphoma patients with CIN were HD patients. The
proportion of HD patients with CIN (32%) was not, however,
significantly different from the proportion of non-Hodgkin's
lymphoma patients with CIN (0%) (p > 0.05) by Fisher's exact
probability test.
Table 20 shows that the lymphoma patients with cervical
koilocytosis without CIN were older, more likely to be parous and
became sexually active rather later than the patients in whom no
significant abnormality was detected. They had also had their
lymphomas diagnosed for longer periods. Lymphoma patients with CIN,
on the other hand, were younger, commenced sexual activity earlier
and reported more sexual partners than did the patients in whom no
abnormality was detected, although these differences were not
149.
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57 (72) 13 (48)
Koilocytosis only 14 (28) 8 (30) NS
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CIN I 6 (8) 1 (3) NS
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%2 = 8.33 p < 0.01 (lymphoma patients versus controls)
aaa
V = 5.8 p < 0 .02 (lymphoma patients versus controls)
NS = not significant
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statistically significant (0.1 > P > 0.05 by Mann-whitney U test).
Lymphomas had been diagnosed in these patients prior to colposcopic
examination for approximately the same length of time as in the
lymphoma patients with normal cervices.
Discussion
A significantly higher prevalence of CIN II and III was
demonstrated in lymphoma patients than in a control group of women.
Ideally each case should have been compared with two or three
controls, matched with the case for known risk factors. However,
colposcopic examination and biopsy is an invasive procedure and,
when carried out on patients anaesthetised for dilatation and
curettage or laparoscopic sterilisation, significantly increases the
duration of the general anaesthetic. The recruitment and
examination of the much larger number of controls necessary for this
approach would have presented considerable practical problems and it
was therefore decised that it was justifiable to compare lymphoma
patients with available controls, matched only for age and oral
contraceptive use. In fact the control patients reported on
average more sexual partners and an earlier coitarche and were more
likely to smoke than the lymphoma patients (see table 17). A
higher prevalence of CIN in the controls than in the lymphoma
patients would be predicted on the basis of these known risk factors
(La Vecchia, 1985, Winkelstein et al, 1984). However the reverse
was found, that is a significantly higher prevalence of CIN II and
III in lymphoma patients than in controls. This lends support to
the contention that lymphoma patients are at increased risk of
developing CIN and that this risk is independent of known risk
factors such as sexual behaviour and smoking. It is noteworthy
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that the lymphoma patients found to have CIN reported having had
more sexual partners than did either the lymphoma patients without
CIN or the normal controls (see tables 17 and 20).
The malignant potential of CIN II and III is well defined with
few cases regressing. The natural history of CIN I, on the other
hand, is still controversial (Campion et al, 1986) as studies
relying on cytology alone have tended to underestimate the severity
of the initial lesion while those employing colposcopic punch biopsy
have found this procedure to be curative in some cases, thus
artifically increasing the "regression" rate (Koss, 1978). In view
of this uncertainty patients and controls with CIN I were separated
from those with CIN II and III for the purpose of statistical
analysis.
The increased prevalence of CIN in lymphoma patients is in
agreement with the increase in other malignancies seen in these
patients (Coleman et al, 1982; Tester et al, 1984) and may be due
to immunosuppression. Five of the six lymphoma patients with CIN
had received chemotherapy, which contributes to immunosuppression in
these patients (Schilsky and Erlichman, 1982). It should, however,
be remembered that patients receiving chemotherapy tend to have more
extensive disease so that the apparent association between CIN and
chemotherapy may be due to the immunosuppressive effects of the
disease rather than the effects of chemotherapy. This question
will be explored further by studying breast cancer patients treated
with alkylating agents in an attempt to separate the effects of
these agents from the effects of the lymphoma.
It is interesting that no CIN was detected in non-Hodgkin's
lymphoma patients treated with chemotherapy. Less is known about
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the risk of second malignancies in non-Hodgkin's lymphomas than in
HD but the risk of acute myeloid leukaemia in patients treated with
alkylating agents for non-Hodgkin's lymphomas appears to be similar
to the risk seen in HD patients treated with these agents
(Pedersen-Bjergaard et al, 1985). In this study there were only
four patients with non-Hodgkin's lymphomas who received chemotherapy
so that no firm conclusions can be drawn.
Of the six lymphoma patients with CIN, five had had cervical
smears performed within the preceding four years, but only one of
these smears was reported, on routine screening, to be abnormal.
When smears were taken under optimal conditions at colposcopy and
examined carefully three of six cases of CIN were still undetected.
The insensitivity of cervical cytology has been appreciated since
1970 when Coppelson reported colposcopic persistence of dysplasia
despite reversion to normal of abnormal cervical smears. This
finding has been confirmed recently by Davis et al (1987) and
Kitchener et al (1987) while Campion et al (1986) studied women with
mild cervical atypia and found that of the women whose disease
progressed to CIN III, 15% had had two consecutive false negative
smears. Giles et al (1988) surveyed 200 normal women and found
that 22 (11%) had CIN. Cervical cytology failed to detect seven
(32%) of these cases.
The data reported here is in agreement with these results,
lending support to the increasingly popular view that cervical
cytology alone is inadequate as a screening technique for women at
high risk of CIN.
Fifty-two per cent of lymphoma patients had cytological and/or
histological evidence of cervical HPV infection, alone or in
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association with CIN. This was significantly higher than the
proportion of control patients with cervical HPV infection (see
table 19). However, it should be noted that the lymphoma
patients with koilocytosis only, in the absence of CIN, are, on
average, 11 years older than those with CIN and have been sexually
active for 6.6 years longer than CIN patients (see table 20). The
"koilocytosis only" patients were also diagnosed as suffering from
a lymphoma 18 months earlier than the CIN patients (i.e. 57.8
months before colposcopy versus 39 months). These data tend to
argue against HPV infection being a premalignant condition and
certainly demonstrate that even in immunosuppressed women,
neoplastic change does not inevitably follow. Other factors
including, in these patients, the degree of immunosuppression and
the carcinogenic potential of drugs given, as well as recognised
risk factors such as early onset of sexual activity, multiple





This thesis would undoubtedly have benefitted from the
inclusion of a larger number of colposcopically screened normal
controls. The controls studied in Chapters 4 and 5 were patients
referred to the Colposcopy Clinic on account of a cervix thought to
be clinically suspicious, but with normal cervical cytology,
colposcopy and histology, and patients undergoing unrelated
gynaecological procedures with normal cervical cytology. They were
chosen because they were easily accessible, and because taking
cervical brushings or biopsies from them did not cause delay in the
clinic or the operating theatre and did not inconvenience other
members of staff. It was considered clinically appropriate to take
cervical biopsies from the normal controls seen at the Colposcopy
clinic to confirm the absence of neoplastic disease. Patients
undergoing unrelated procedures gave informed consent for cervical
punch biopsy, and did not experience discomfort because they were
anaesthetised.
The Group 'C' controls who are described in Chapters 3 and 6
are, perhaps, more acceptable as normal controls. They were
patients with normal cervical cytology who underwent colposcopy and
cervical punch biopsy at the time of an unrelated minor
gynaecological procedure such as dilatation and curettage or
laparoscopic sterilisation. The recruitment and examination of
these patients involved considerable disruption to operating lists
which were already full, and it could be argued that they are not
156.
ideal normal controls either. They were older, on average, than
the patients with CIN, reflecting the general tendency for patients
undergoing gynaecological operations to be older than those
attending colposcopy clinics. It might be predicted that women
undergoing laparoscopic sterilisation will be more highly parous
than the general population but, in fact, there was no significant
difference in parity between group * C * controls and CIN patients.
Patients undergoing dilatation and curettage may be suffering from a
hormone imbalance related to dysfunctional uterine bleeding and in
view of the controversy surrounding the role of oestrogen and
progesterone in the aetiology of CIN (see p .27) are perhaps not
ideal controls. Perhaps the best controls would be patients
attending a family planning or well woman clinic for routine
cervical screening. The recruitment and examination of these women
would, however, have involved considerable organisation and
additional work for both the author and for other members of staff
and was therefore not performed.
The group 'B' normal controls (women undergoing unrelated
gynaecological procedures) had normal cervical cytology but did not
have colposcopic examination carried out. The relative
insensitivity of cervical cytology is well recognised (see p. 110)
so that CIN cannot reasonably be said to have been excluded
unless a colposcopic examination has been carried out. The
results of the present study confirm this, in that three of six
cases of histologically proven CIN in lymphoma patients, and seven
of eight cases in control patients were undetected by cervical
cytology. In addition all specimens obtained should have been
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analysed for the presence of HPV antigen or viral DNA, as 38% of
cervical brushings and biopsies from otherwise normal cervices
contained HPV antigen, and similar percentages (in relation to viral
DNA) are reported from other groups (Cox et al, 1986; Schneider et
al, 1987).
It should, however, be remembered (as discussed in Chapters 4
and 5) that significant differences were detected between the
so-called normal controls and the patients with proven cervical HPV
infection or CIN, in terms of LC numbers, MHC class II expression,
cell cycle analysis and ploidy. If the control group did contain
patients with undetected HPV infection or CIN it can be predicted
that the differences between a "pure" control group and HPV and CIN
patients would be greater, rather than less.
The conclusions drawn from the work described in Chapters 4, 5
and 6 may therefore be regarded as valid and as under-estimating,
rather than over-estimating, the differences between normal and
abnormal cervical epithelium.
The results reported in Chapter 4 of this thesis support the
contention advanced by other investigators that there is a
disturbance of local immune function in papillomavirus infected
cervical epithelium, and in CIN. LC and T cells were found to be
reduced in number in HPV infected epithelium and in CIN. MHC
Class II antigen expression by LC was, in addition, significantly
increased in CIN.
It has been suggested that HPV has a cytopathic effect on LC
(Morris et al, 1983) or that LC surface antigens may be altered or
blocked by the presence of HPV (Hawthorn et al, 1988). One or both
of these mechanisms may account for the reduced LC numbers and
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altered LC morphology noted in HPV infected epithelium. It is also
possible, however, that intraepithelial LC are reduced in number
because they migrate out of virally infected epithelium in a manner
similar to that seen following ultraviolet irradiation of skin
(Gurish et al, 1982). It would be interesting, in this context,
to study LC numbers in adjacent "normal" cervical epithelium, to
discover whether cell counts are unchanged or reduced, relative to
normal, as might be expected if the virus destroys intralesional
LCs; or increased as might occur if the virus causes migration out
of the lesion. Morris et al (1983) examined normal epithelium
adjacent to CIN and found LC counts to be similar to counts in
normal epithelium from controls. It is, however, difficult to
obtain a truly "normal" biopsy as apparently normal epithelium
adjacent to CIN or koilocytic lesions has been shown, repeatedly,
to contain HPV DNA (Ferenczy et al, 1985; MacNab et al, 1986).
The demonstration here of HPV antigens in the tumour-free
pelvic lymph nodes of patients undergoing hysterectomy for cervical
carcinoma (see Chapter 5) would support the theory that infected
LC, or LC bearing HPV antigen, do migrate from HPV infected
epithelium to draining lymph nodes. It would, however, be
necessary to employ a double staining technique to identify the
cells within the node containing, or bound to, HPV DNA or antigen
to ascertain whether these cells are, in fact, LCs. This would be
most helpful in advancing our comprehension of the local immune
response to HPV which is so limited at present.
Once HPV infection has caused intraepithelial LC depletion (by
causing LC damage or migration) it is postulated that neoplastic
change can occur, undetected by the normal immunosurveillance
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mechanisms (Morris et al, 1983). HPV may play a dual role in the
causation of cervical neoplasia, allowing neoplastic change to
occur undetected and, in addition, stimulating cell division.
It would be interesting to look at LC numbers in epithelium
infected with other viruses, to discover whether LC depletion is a
non-specific viral effect. There is little published work in this
area to date. Bhawan et al (1986) report a total absence of LC in
molluscum contagiosum, with normal or increased numbers in
peri-lesional normal skin and postulate that alterations in the
differentiation and maturation of keratinocytes in these lesions
may lead to an inhibition of LC migration into the epidermis.
Nagao et al (1976) studied LC at the site of vaccinia virus
inoculation and comment that intralesional LC contained increased
numbers of granules. They do not, however, give details of
absolute numbers of LC.
In this study LC were also found to be reduced in number in
CIN. Other investigators have reported conflicting results (see
Chapter 1 p.50), but in general LC are reported to be reduced in
number in and around malignant tumours (Gatter et al, 1984). It
is interesting that patients with progressive disease, and
patients with residual or recurrent CIN following ablative therapy,
were found to have had lower LC counts at their first visit then
those who were found to be free of disease at one year follow-up.
This corresponds with the findings of Syrjanen et al (1984) who
noted that LC counts were lower in patients whose disease
progressed than in those whose disease regressed, and is further
evidence to support the idea that LC play a role in tumour
immunosurveillance at this site.
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Increased class II antigen expression by LC was demonstrated
in koilocytic lesions and in CIN, and may represent a higher level
of "activation" of the cells. The work of Navaretti et al (1985a
and b) concerning the role of HLA-DQ in the generation of a
suppressor type response is discussed in Chapter 5. At present
little is known about the functional significance of the
differential expression of HLA-DP, DQ and DR but it is possible
that increased expression of HLA-DQ in CIN I (as described in
Chapter 5) does induce a predominantly suppressor response thus
allowing neoplastic progression.
The expression of MHC Class II antigens by epithelial cells in
CIN was described by Morris et al (1983) and is confirmed here.
It may be a reflection of the lack of differentiation of the
epithelium but may also have important implications concerning the
local intraepithelial immune response. Again, little is known
about the functional significance of MHC Class II expression by
non-lymphoid cells but it would be interesting to compare the
clinical outcome of untreated Class II positive and negative
lesions.
The work reported in Chapter 6 comparing the prevalence of CIN
in lymphoma patients with its prevalence in normal controls
provides further evidence to support the theory that an intact
immune system is necessary to prevent the development of CIN. The
number of patients studied was, of necessity, very small but if the
detection of CIN in 38% of women with Hodgkin's disease who had
received chemotherapy is confirmed by studying a larger group this
will have important implications for the management of these
patients, the majority of whom have a life expectancy of at least
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15 years. It is not clear from this study whether the increased
risk of CIN detected in patients with Hodgkin's disease can be
attributed to the lymphoma or to the effects of the
chemotherapeutic agents used. A study has begun of patients with
breast cancer treated with similar agents in an attempt to separate
the effects of the lymphoma from the effects of therapy.
The cervical cytology data acquired in this part of the study
is of clinical concern and would support the view that cervical
cytology alone, without back-up colposcopy or histology, is an
unacceptably insensitive technique when used to screen women with
known cervical abnormalities. The implications for screening of the
general population and of women at high risk of developing CIN, are
less clear. The true false negative rate in the general population
will not be known until a study combining cytology, colposcopy and
histology in the examination of a large number of normal women is
performed, but Giles et al (1988) suggest that the rate may
approach 32% (see page 153 )•
The rate of cell division in koilocytic and papillomavirus
antigen positive cervical epithelium was found to be higher than in
normal epithelium, and to be similar to the proliferative rate in
CIN. This supports the hypothesis of Reid et al (1982) that the
virus acts as a non-specific mitogen and causes S-phase arrest.
Possibly this is the role of HPV in carcinogenesis; by stimulating
cell division and by arresting cells in the S-phase it simply
provides a greater number of opportunities for mutation and
neoplastic change.
It is easier to reconcile this idea with the detection of HPV
DNA and antigens in a significant proportion of normal cervices
162.
(here, and Meanwell et al, 1987) and in other normal tissues
(Maitland et al, 1987; Ferenczy et al, 1985) than it is to
postulate that the virus consistently causes genetic aberrations
and malignant change. It should be noted that HPV antigens are
not detected in invasive carcinomas, although viral DNA is known to
be present, and there is evidence that viral DNA is not transcribed
in all HPV positive tumours (Lehn et al, 1985; Yee et al, 1985)
which argues against an active role for the virus as a source of
tumour antigen. HPV type and integration of viral DNA may both be
important factors which were not explored at all in this thesis.
More surprising, perhaps, was the detection of DNA aneuploidy
in koilocytic lesions, in the absence of any detectable CIN. This
suggests that the virus induces potentially malignant changes in
cellular DNA which can be detected before any phenotypic change has
occurred. This appears to be an important piece of evidence
supporting the theory that HPV behaves as a carcinogen in the
cervical transformation zone. It is important to remember,
however, that aneuploidy has been reported in benign lesions with
no known malignant potential (see Chapter 1, p. 57) and that some
aneuploid cervical lesions have been shown to regress (Nasiell et
al, 1979). It would be most informative to look for DNA aneuploidy
in lesions induced by HPV types 1 and 2 which have no known
malignant potential and in warts from immunosuppressed individuals
including those with epidermodysplasia verruciformis. The results
obtained from the various experiments described in this thesis
demonstrate a consistent difference between HPV infected and normal
epithelium, and a consistent similarity (in terms of patterns of
cell division, ploidy, oncogene expression and LC and T cell
163.
infiltrates) between HPV lesions and CIN. There was no real
evidence of an increasing trend in the detection of any of these
features as "progression" occurred from HPV infection to CIN,
arguing perhaps, against HPV infection being a precursor of CIN.
The techniques employed in this study (in particular the use of
monoclonal antibodies, and flow cytometry) were not in use when
interest centred on herpes simplex virus type 2 as an aetiological
agent in cervical carcinoma. It would be very interesting to use
these methods to discover whether the abnormalities found in
association with HPV infection are also associated with infection
by other microorganisms, including HSV-2.
It is, nevertheless, striking that HPV infected and neoplastic
epithelium examined by very different methods and assayed for very
different criteria should be so difficult to distinguish from one
another. Perhaps papillomavirus infection is a necessary
precursor for neoplastic change, but progression only occurs in the
presence of a factor or factors not identified by these experiments
but which probably include immunosuppression (local or systemic)
and hormonal status and may include smoking, infection with other
viruses, particular characteristics of the male partner's semen and
genetic predisposition. Carcinogenesis is well recognised to be a
multifactorial phenomenon (Berenblum, 1941) and it seems unlikely
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lesions caused by papillomaviruses tend to be persistent and are
characterised by increased proliferative activity. These features, as
well as the results of animal studies,2 make the viruses attractive
candidates for playing a part in human carcinogenesis.
Most human cervical carcinomas contain aneuploid cell popu¬
lations,5 and a variable proportion of cases ofcervical intraepithelial
neoplasia are also aneuploid.4 In addition, the number of proliferat¬
ing cells in a tumour increases with increasing malignancy.5 Since
the introduction of flow cytometry it has become possible to identify
aneuploid populations with greater accuracy and to quantify the
fraction of a cell population in each phase of the cell cycle. In this
study we used an EPICS flow cytometer to examine both of these
aspects in cervical intraepithelial neoplasia and in infection of the
cervix by human papillomavirus.
Patients and methods
Patients—We studied 79 patients aged 22 to 47 referred to the Lothian
area colposcopy clinic with abnormal cervical cytology or a clinically
suspicious cervix. Ten women aged 25 to 43 who had a history of normal
results of smears and who were undergoingminor gynaecological procedures
were included as controls.
Biopsies—A cervical biopsy sample was taken from the transformation
zone of each patient and control; all the samples from the patients came from
areas shown to be abnormal by colposcopy. The specimen was snap frozen
on dry ice and stored at -80°C until processed further. A single 8 pm
cryostat section was taken from the centre ofeach specimen and prepared for
routine histopathological examination with a conventional haematoxylin and
eosin stain. Cervical intraepithelial neoplasia was classified according to
recognised criteria.6 Koilocytes (balloon shaped cells with a perinuclear
halo) were considered to be diagnostic of human papillomavirus infection.7
The remainder of the biopsy sample was then thawed, minced, and
incubated in 3 ml 0 5% solution of pepsin (Sigma) in O'OIM phosphate
buffered saline, with the pH adjusted to 15 with hydrochloric acid, at 37°C
for one hour. The supernatant was drawn off and centrifuged at 2000 g for
10 minutes, and the resultant pellet was washed in phosphate buffered saline
and respun at 2000 g for 10 minutes.
Staining—The nuclear suspension was stained with a modified method of
Deitch et al.' The pellet was dispersed in 2 ml solution containing 50 pg
propidium iodide (Sigma) per ml in O'OIM trometamol (TRIS) (pH 7 0)
with 5 mM magnesium chloride, 0-1% Triton X-100, and 15 pg ribo-
nuclease (Sigma) perml and incubated at 4°C for one to 24 hours. The nuclei
COPYRIGHT © 1987 All rights of reproduction of this reprint are reserved in all countries of the world
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were then centrifuged at 2000 g for 10 minutes and resuspended in
phosphate buffered saline.
Controls for flow cytometry—Red blood cells from chickens were run with
each sample as an internal control, the DNA content of such cells being 35%
of that of a human diploid cell.' They were stained with the propidium
iodide solution as described above. Human peripheral blood lymphocytes
were stained and run with chicken red blood cells as an external control at the
start of each run.
Flow cytometry—The flow cytometer used was an EPICS C (Coulter)
DNA index of 1 equalled the DNA content of a diploid cell. A
considered to contain an aneuploid component if the DNA in
than 0 9 or greater than T1 or if it contained a main subsidiary p
distinct from the Go/G! (diploid) and G2 +M peaks. All foi
groups yielded some aneuploid samples, the proportion of am
ranging from 14 3% (cervical intraepithelial neoplasia grade
(grade III). Of the 15 aneuploid samples identified, six were
(DNA index <0 9) and nine were hyperdiploid (DNA index
DNA index of hyperdiploid cell populations was always less th,
Proportion ofnuclei from cervical biopsy samples in various phases ofcell cycle and number ofsamples containing aneuploid cells
Result of
histopathological examination
No of samples suitable
for parametric analysis
% (SD) Ofnuclei in
S phase
% (SD) Of nuclei in
S+G2+M phases Significance*
No (%) of samples containing
aneuploid cells
Normal 10/10 11-97 (4 00) 21-60(4-51) 0 (0)
Koilocytosis alone 10/11 20-64(8-62) 31-20 (8-53) p<005 2(18)
Cervical intraepithelial neoplasia:
Grade I 14/14 23-25(9-36) 33 06(8-71) p<001 2(14)
Grade II 20/21 19-80 (7-74) 29-89(8-39) p<001 4(19)
Grade III 31/33 18-27 (5-80) 31-76 (8-38) p<001 7(21)
*Comparison with normal group by Mann-Whitney U test.
equipped with an argon ion laser that used 200 mW power and emitted light
at 488 nm. The nuclei were run at a rate of 150/second until 20000 stained
nuclei had been counted.
Analysis ofdata—The data obtained were subjected to parametric analysis
with the EPICS PARA 1 program, which determined the proportion of
nuclei in each phase of the cell cycle. The significance of the differences in




The table shows that of 89 cervical biopsy samples examined, 10 were
classified by histopathological criteria as normal squamous epithelium, 11 as
containing areas of koilocytosis without evidence of cervical intraepithelial
neoplasia, and 68 as showing evidence of cervical intraepithelial neoplasia:
14 grade I, 21 grade II, and 33 grade III. Four specimens produced
histograms on flow cytometry that, because of an abnormal distribution of
DNA, were unsuitable for parametric analysis and were omitted from this
part of the study.
The table also shows the proportion of cells in the S phase (the phase of
DNA synthesis) and in the G2 (the phase after DNA synthesis) + M (the
phase ofmitosis) phases of the cell cycle. The figure shows the data obtained
from one biopsy sample.
Traditionally, studies of cellular proliferation have examined only the
fraction of cells in the S phase, as the cells in the G2+M phases could not be
quantified by the uptake of tritiated thymidine. Two of us (RH and WN)
analysed the histograms independently and found that calculating the total
proportion of cells in the S+G2+M phases was less subject to variation
among observers than calculating the proportion ofcells in the S phase alone,
though as can be seen from the table the twomeasurements gave very similar
results.
The fraction containing cells in the S phase increased from 11 ■ 97% of the
total in normal epithelium to 20-64% in epithelium containing koilocytes
but no cervical intraepithelial neoplasia (p<0-05). The samples from
patients with cervical intraepithelial neoplasia all contained significantly
more cells in the S phase than those from the control group. There were no
significant differences between the group with koilocytosis and the group
with cervical intraepithelial neoplasia. When the S and G2+M phases
were considered together a similar pattern was seen. All four groups with
abnormal samples (koilocytosis alone, cervical intraepithelial neoplasia
grades I, II, and III) contained significantly more cells in the"+G2+M
phases than the control samples but did not differ significantly from each
other.
ANEUPLOIDY
The DNA index was calculated from the ratio between the chicken red
blood cell and sample modal channel numbers versus the ratio between
chicken red blood cell and lymphocyte modal channel numbers. Thus a
Discussion
Our analysis of cellular DNA content by flow cytor—
that normal cervical epithelium can be distinguishei
thelium with koilocytosis (evidence of human pa[_
infection) and with cervical intraepithelial neoplasia,
with koilocytosis or cervical intraepithelial neoplasia d—









































Intensity of red fluorescence
(arbitrary units)
Result of flow cytometry of nuclear DNA from cervical biopsy-
within set of cursors marked (a) and G2+M peak within cur
S phase fraction lies between two sets of cursors, and chicken ret
form peak to left of (a).
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:11s in S+G2+M phases) and, in some cases, possessing
lploid component. In many systems aneuploidy and
lased rate of cellular proliferation are characteristics of
ncy.
; been postulated that cells infected with papillomavirus
behave as though stimulated by a non-specific mitogen and
a semipermissive epithelium many cells remain in a
:d S or G2 phase.10 Reid proposed that cumulative mitotic
1 these stem cells might result in occasional chromosomal
is spawning clones of aneuploid basal cells." By showing an
-i proportion of cells in the S+G2+M phases in the
c group ourwork supports this view. The samples from the
ntraepithelial neoplasia grade II and III lesions contained a
-proportion of proliferating cells than samples from the
c and cervical intraepithelial neoplasia grade I lesions,
-he difference was not significant. This fits Reid's hypo-
at the virus initially stimulates epithelial proliferation
0 arrest in the S phase and the emergence of aneuploid
>ns.
jast with the work done by other groups412 the prevalence
oidy did not increase significantly with increasing severity
1 intraepithelial neoplasia in this study. The proportion of
ontaining aneuploid populations was essentially similar in
=abnormal groups, including the group with koilocytosis
lge 14"4% to 2T2%). To our knowledge this is the first
I report of aneuploidy in "benign" human papillomavirus
of the cervix, and it supports the hypothesis that human
virus does have a central role in the aetiology of cervical
1.
tion, the implications for the management ofpatients with
nee of cervical human papillomavirus infection or of
ttraepithelial neoplasia grade I may be far reaching. In
tres these women are treated conservatively in the hope
:sion will regress. It has been suggested that the clinical
behaviour of lesions may be predicted on the basis of the degree of
ploidy." On the other hand, our data seem to indicate that so called
benign human papillomavirus infections and cervical intraepithelial
neoplasia grade III share similar patterns of DNA synthesis and
thus should be treated identically.
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